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ABSTRACT 
The objective of this Ph.D. study was to develop new and improved miniaturized 
particle-based optochemical sensors for the analysis of biological fluid and cellular components. 
This is highly important because current sensing systems can be biologically toxic and 
incompatible, invasive, and have limited responsiveness.   
To accomplish this goal we defined three tasks. The first was to develop lipobead-based 
sensors for chloride. The halide-specific fluorescence dye, lucigenin, was immobilized into the 
phospholipid membrane of the lipobeads to enable chloride ion detection.  The fluorescence 
intensity of lucigenin decreases with increasing chloride ion concentration due to dynamic 
quenching. To stabilize the lipobeads we co-immobilized hexadecanesulfonate molecules into 
the phospholipid membrane. We also immobilized the chloride ionophore [9] mercuracarborand-
3 (MC-3) into the lipobeads membrane.  The study resulted in a unique submicrometric chloride 
ion sensor, which is suitable for chloride ion measurements in biological fluids. 
The second task was to develop for the first time lipobead-based biosensors. Urea was 
chosen as a model substance since the urea/urease biosensing system is well known. 
Fluorescence sensing lipobeads were characterized by coating carboxyl-functionalized silica 
microspheres with phospholipids for the measurement of urea in aqueous samples.  The enzyme 
urease and the pH indicator Fluorescein-5-thiosemicarbazide were attached covalently to the 
phospholipid membrane of the lipobeads. We prepared improved fluorescence sensing lipobeads 
by utilizing covalent chemistry to bind the phospholipid membrane to the silica particles and the 
fluorophores to the membrane.  It led to improvement in the stability of the newly developed 
urea sensing lipobeads compared to previously developed micrometric fluorescence sensors. 
 ix 
 
The final task of this study was to coat particle-based sensors with cell penetrating 
peptides to enable their permeation into cells. This step is essential for the use of particles as 
intracellular sensors. Streptavidin coated microspheres were modified by the strongest 
noncovalent interaction between avidin and biotin. Tat peptide and nonfluorescence indicator 
flubida were attached to the surface of the microspheres. These nanoparticles were delivered into 
MCF7 and Hela cancer cells for pH measurement. Before penetrating into the cells, flubida did 
fluoresce in cell medium; however it did not convert to fluorecein in Phosphate Buffered Saline 
(PBS) buffer.   
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CHAPTER I INTRODUCTION 
 
1.1 Objectives and Aims 
 
Previous work in synthesizing and developing analyte specific sensors in our lab has 
often encountered problems with reducing the size of particles for use as the sensing probes.  
Therefore, the main objective of my work was to develop new and improved miniaturized 
particle-based optochemical sensors for the analysis of biological fluid and cellular components.  
The specific aims of my work were: a) to develop lipobeads based sensors for chloride 
measurement, b) to develop lipobead sensors for urea measurement, and c) to demonstrate that 
these particles could also penetrate into cells to facilitate intracellular measurements. 
 
1.2 Significance and Impact 
There are numerous drawbacks for previously developed 100 times larger sensors when 
applied to biological systems. These include invasiveness that often leads to cell and tissue 
damage, slow response time and limited spatial resolution. Therefore, there is a need to develop 
new smaller sensors that have reduced or eliminated these drawbacks. In our lab we have 
developed submicrometric particle-based sensors which have greatly reduced much of the 
drawbacks listed above.  The particle based sensors that were developed during my Ph.D studies 
generate significant improvements over previously developed particle based sensors such as 
improved physical stability, low cost of ingredients, reduction of carrier system leakage (e.g. 
drugs or probes leakage), increased ease of preparation, and improved yields, particularly for 
sensors that are used for hydrophobic indicators.   
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The newly developed particle-based sensors are phospholipids coated polymer particle, named 
lipobeads. Their successful preparation enabled their application in cellular studies requiring the 
use of non-invasive probes with high temporal and spatial resolution. Beyond the analytical 
impact of this Ph.D study, it is anticipated that this new sensing technology will enable better 
understanding of signaling events leading to the on-set of various pathologies including the 
genetic diseases cystic fibrosis (chloride sensors) and renal diseases (urea sensors). The ability to 
deliver sensing particles into cells as described in chapter 5 could lead in the future to the 
development of intelligent sensing systems with the capability to identify abnormal cells, 
permeate them and release drug molecules inside abnormal cells in response to a triggering 
signal sensed by the particles. This has the potential to revolutionize the ways currently used to 
deliver drugs in treating diseases. 
  
1.3 Fluorescence Principle 
1.3.1 Jabloński Diagram 
 
Jabloński Diagrams describe light absorption and emission and demonstrate different 
molecular processes happening in the excited states during fluorescence. In a typical Jabloński 
Diagram, S0 shows a singlet ground state, and S1 and S2 show first and second excited states, 
respectively. At each different state, the notation 0, 1, and 2 mean different vibrational energy 
levels. T1 means the first triplet state. When a fluorophore absorbs light, it will excite from the 
singlet ground state to the first or second excited states. Internal convension usually occurs when 
the excited fluorophore molecules relax from the second excited state to the first excited state. 
This process normally happens before the emission starts, so generally we see the absorption and 
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emission spectra are the mirror images of each other because the electrons excited do not change 
the nuclear geometry. Intersystem crossing happens when the electrons in the first excited state 
S1 transit to the triplet state T1. This process will emit phosphorescence which is lower in energy 
compared to fluorescence. Figure 1.1 is an illustration of a typical Jabloński diagram. 
 
S0
T1S1
S2
Phosphorescence
Intersystem
  Crossing
Absorption Fluorescence
Ground State
Excited State
   Internal
Conversion
Vibrational
Relaxation
 
 
 
Figure 1.1 Jabloński Diagram. 
 
1.3.2 Excitation and Emission Spectra 
Fluorescence measurements typically involve recording excitation and emission spectra. In 
this study the fluorescence emission spectra were used often to characterize the sensing 
properties of particles and fluorophore solutions. Emission spectra depict the emission intensity 
as a function of wavelength when the sample is excited using a single wavelength. Excitation 
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spectra depict the fluorescence intensity at a fixed emission wavelength against the wavelength 
of the excitation light. Different fluorophores have variable excitation and emission spectra that 
are determined by the fluorophore’s chemical structures and the solvent used.  
 
1.3.3 Collisional Quenching 
  Fluorophore self-quenching, due to its own high concentration, is a fundamental 
phenomenon that is one type of fluorescence quenching.  Fluorescence quenching occurs when 
the fluorescence intensity decreases due to an energy transfer process. The most widely used 
quenching is collisional quenching. Collisional quenching results in a fluorescence intensity 
decrease when the fluorophores in the ground state come in close proximity to the quencher, then 
return to the ground state without emitting fluorescence. Collisional quenching includes static 
and dynamic quenching. Static quenching occurs when nonfluorescent complexes form between 
the fluorophore in the excited state and a quencher. This complex returns the fluorophore in the 
excited state to the ground state without emitting fluorescence. Dynamic quenching happens 
when during the fluorophore’s lifetime in the excited state; the fluorophore diffusively 
encounters a quencher and returns to its ground state without emitting photons. Quenching can 
be described by the following Stern-Volmer equation: 
 
F0/F= 1+K [Q] =1+kq τ0 [Q] =1+ KD [Q]     (1) 
 
Where F0 and F are the fluorescence intensities in the absence and presence of the quencher, 
respectively, and K is the Stern-Volmer quenching constant.  For the static quenching, K is Ksv, 
which is Sten-Volmer constant, higher Stern-Volmer constant, higher sensitivity to chloride. For 
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the dynamic quenching, K represents KD. [Q] is the quencher concentration, kq is the bimolecular 
quenching constant, and τ0 is the fluorophore lifetime in the absence of quencher. When we 
analyze the data, we plot F0/F versus [Q]. The slope of the curve is equal to the Stern-Volmer 
quenching constant.  
There are numerous ways to distinguish between static and dynamic quenching.  The most 
direct way is to measure their fluorescence lifetimes. For the static quenching, the fluorophore’s 
lifetime does not change with [Q] because the fluorophore-quencher complex does not emit 
fluorescence. However, for dynamic quenching, the fluorophore’s lifetime changes with [Q]. As 
more collisions occur, lifetimes are shorter, and the fluorescence intensity is lowered. Quenching 
at different temperatures and viscosity will have different Stern-Volmer constants.  When the 
temperature is higher, the quenching constant is lower for static quenching and higher for 
dynamic quenching .   
 
1.4 Fluorescence Sensors 
Two typical classes of fluorophores are intrinsic and extrinsic. The extrinsic fluorophores 
are primarily used to label nonfluorescent molecules while intrinsic fluorophores are utilized 
when analytes naturally fluoresce. Our discussion here involves extrinsic fluorophores that 
respond to certain substrates of interest.  
 
1.5 Particle Based Fluorescence Sensors 
1.51 Single Cell Analysis 
In living organisms cells are the fundamental units. Different organs of mammals have 
different kinds of cells. The direct observation of single cells using fluorescence techniques has 
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become a powerful investigative tool for analyte measurement. It can dramatically help us 
understand cellular metabolism, signal transduction (1-5), gene transcription (6, 7), and 
intracellular transport and fate of delivered drugs. The methodologies used must provide 
sensitive and fast analysis for the single cell measurement due to the tiny amount of sample 
present inside the cell. Fluorescence microscopy and flow cytometry are the most popular 
cellular analysis techniques (8-11). In fluorescence microscopy the cell is excited with one 
wavelength of light and the emitted fluorescence from the excited fluorophores is collected by 
detection systems such as photomultiplier tubes.  The flow cytometer uses a laser to light up cells 
going by in a stream. The incident light is diffracted by the cells and also absorbed by 
fluorophores in the cells. A photomultiplier tube is used to collect the emitted fluorescence from 
the fluorophores within the cells. These two techniques have the common feature that molecular 
fluorescent probes have to be employed to label the observed cells. Fluorescence microscopy is 
used for real-time continuous observation of cells.  It is different in flow cytometry where each 
cell is observed only once as it flows through the detection system, even though it includes high-
speed acquisition of information on the individual cells.  
 
1.5.2 Phospholipids Properties 
The components of cells are large molecules, among which lipids are one of the most 
important. In Greek, the word lipid comes from lipos, which means fat. The most widely used 
classification of the lipids includes simple lipids, compound lipids, and derived lipids (12).  
Simple lipids include neutral fats and waxes, compound lipids are composed of phospholipids 
which contain phosphate head groups, cerebrosides, gangliosides which involve a carbohydrate 
group, and sulphatides which are lipids having a sulphate residue. In this chapter we are 
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interested in phospholipids that we use to simulate the biological membrane for particle delivery 
into cells. 
Phospholipids are the major components of biological membranes. Most phospholipids 
are made up of hydrophilic polar head groups and hydrophobic fatty acid chains.  Although the 
structures of the various phospholipids are very similar, the differences among them still exists, 
which includes fatty acid compositions, acyl chain unstauration, and polar head groups. These 
small differences determine their membrane physical properties, their locations and their 
biological functions. 
It is very important to understand phase transition and the fluidity of phospholipids 
membranes (13, 14). The different phospholipids membrane phases will demonstrate different 
ion permeability, ability to bind to proteins, degree of aggregation and fusion, and their 
biological behaviors. Phase transition means that at different temperature, the hydrocarbon 
chains of the phospholipids exhibit a different degree of molecular motion. One type of 
phospholipids can expand to have several phase temperatures. At the first transition point, the 
molecular motion of the fatty acid chain increases. With the temperature increase, the chain 
motion possibly involves molecular rotation, translation or diffusion. The phase transition is at 
low temperatures for the short chain length or unsaturated bonds. For the totally saturated long 
chain phospholipids, the phase temperature is higher. If the phospholipids have the same fatty 
acid chains and different head groups, their phase temperatures are still different.   
We use artificial phospholipids membranes to simulate biological membranes. Some of 
the properties of artificial phospholipids membranes are similar to some of the biological 
membranes, e.g. water permeability, interfacial tension, and electrical capacitance. The artificial 
phospholipids membranes can be used to alternate ion conductivity for biochemistry reaction 
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transduction. The electrical charge would be induced due to a rapid structural change on the 
phospholipids membrane, and then an electrochemical signal can be generated on the 
phospholipids surface so an ion current can be provided for electrochemistry (15-17).  However, 
the greatest disadvantage of artificial phospholipids membranes is it being impermeable to ions 
and some other hydrophilic compounds.  
 
1.5.3 Lipobead Based Sensors 
        During the last 20 years, a series of fluorescent probes for cellular analysis have been 
developed. Most of the fluorescent probes are intracellular probes used for the measurement of 
pH and calcium cations in cells (19, 20).  Some examples of probes that have been used for 
cellular analyses are PEBBLEs (probes encapsulated by biologically localized embedding) (21), 
liposomes (22-24), and lipobeads (25-27). PEBBLEs were first developed by Dr. Kopleman at 
the University of Michigan. PEBBLEs are optical nanosensors used for intracellular analyses.  
They are comprised of a polyacrylamide matrix which contains various fluorescent indicators. 
Their size ranges between 20 and 200 nm in diameter so that they are small enough to insert 
inside the cells without damage.  This type of probe has demonstrated fast response times and 
high selectivity, while maintaining biocompatibility.  Two disadvantages of PEBBLEs are the 
fact that they are limited to the use of only hydrophilic dyes, and structural problems that 
constrain their cellular sensing use. Liposome probes are different from PEBBLEs in that they 
are not made up of a solid core, but are comprised of an outer phospholipids layer forming a 
spherical vesicle that has an aqueous core (28).  Liposomes can encapsulate fluorescent 
indicators which can be used for intra-cellular analyses.  Due to the phospholipids outer layer, 
liposomes have been prepared as unilamellar (29), bilamellar (30), or multi-lamellar (31) 
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vesicles.  Advantages include their ability to be used as probes which are non-invasive for tissues 
and individual cells (32-34), and are relatively nontoxic compared to polymeric nanoparticles 
(35). One of disadvantages of the liposomes is that when the probes are released from the 
vesicles, liposomes tend to fuse to the vascular system (36), the other is that due to the vesicle 
size and properties, reproducibility of liposomes are limited. These technological problems 
hinder the widespread use of liposomes. In our lab, we have developed one type of particle-based 
nanosensors called lipobeads that are polystyrene nanoparticles that are coated with a 
phospholipids membrane and hydrophilic or hydrophobic fluorescent indicators are absorbed 
outside or inside the phospholipids membrane (25-27, 37, 38). This type of nanosensor can be 
used for intracellular sensing in physiological conditions. Lipobeads are core-shell structured 
particles, where the core is made of water-dispersible solid microsphere beads.  Their particle 
size ranges between 0.2 to 2.0 um in diameter. In our lab, the shell is composed of one 
monolayer of phospholipids molecules ideally. Other groups have studied a related nanosensor 
called lipospheres (39-50).  These are composed of a hydrophobic fat core that has a surface 
monolayer of phospholipids which helps to stabilize the core (51). Their size is between 0.2 to 
500 um in diameter. They have one disadvantage in that it is difficult to control the particle size 
because of their core composition, as compared to the production of lipobeads, which results in a 
uniform particle size. My continued research will expand the lipobead-based fluorescence 
sensing technology to new analytes of biological importance and greatly increase the ability of 
Dr. Rosenzweig’s group to investigate cellular signaling processes at the single cell level.  
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1.5.4 Intra-Cellular Measurements 
To measure intracellular ion concentration, we have to load the indicators-based material 
into the cell and quantitatively calibrate the free ion concentration inside the cell. There are many 
ways to load fluorescence labeled microspheres into cells such as mechanical loading, chemical 
reagent loading, and electroporation (52). Mechanical loading includes microinjection (53) 
which can be used to load indicators to specific area in neurons, Scrape loading (54) which can 
load macromolecules into the cytoplasm of cells, scratching to wound the culture (55), and mild 
sonication (56). The advantage of this type of methodology is that they are very simple and easy 
to operate; however, the disadvantage is that they are invasive to the cells.  
Currently, the most popular method is to use chemical reagents.  One type is cationic 
transfection reagents (57-59). This method can deliver submicron-sized particles with an 
implantation effiency of ~11% (60). In a typical experiment, certain amounts of submicron 
particles in serum free medium is mixed with the transfection agent well, incubated in serum free 
medium for 4 hrs, washed with complete growth medium, and then incubated with complete 
growth medium for another 24 hrs. The trick of this method is to let the submicron particle 
surface have negative charges. If the particle surface has no negative charges, it will lead to poor 
loading effiency. 
Another method is to use cell-penetrating peptides. This is the method that we chose to 
use in our laboratory. Recent studies have shown that cell-penetrating peptides set up a new way 
for intracellular delivery of particles. This approach can deliver covalently bound particles (size 
up to 150 nm) into cells in vivo.  In our experiment, we use commercially available avidin 
modified polystyrene beads that are covalently bound with biotin modified PEG. We then add 
the Tat peptide and fluorescein onto the surface of the particles. The negative charge of the Tat 
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peptide will interact with the cell membrane and the particles will get through the cell membrane 
and into cells. The trick of this method is that it has to have a spacer between the particles and 
Tat peptide. 
After the particles have gotten inside the cells, we have to calibrate the free ion 
concentration in an accurate way. The calibration measurement needs to add some type of 
ionophore to equilibrate the external and internal ions of the cells, e.g. for pH measurement, we 
use Nigericin as a pH ionophore for intra and outside H+ balance. Generally, we utilize a 
ratiometric calibration method for intracellular measurement. The advantage of this method is to 
avoid artificial variations such as nonuniform loading particles in different part of the cells, cell 
background fluorescence, indicator photobleaching, and instrument variations at different times.   
 
1.6 Previous Work with Lipobead Based Sensors 
In our lab, we have developed one type of particle-based nanosensors called lipobeads 
that are polystyrene nanoparticles that are coated with a phospholipids membrane and 
hydrophilic or hydrophobic fluorescent indicators are absorbed outside or inside the 
phospholipids membrane (25-27, 37, 38). This type of nanosensor can be used for intracellular 
sensing in physiological conditions. The idea of lipobeads is based on the core-shell structured of 
liposome. The core is made of solid microsphere beads instead of aqueous solution, the shell is 
composed of one monolayer of phospholipid molecules. Applications of the lipobead-based 
particles include murine macrophage lysosomal pH measurements (25), murine macrophage 
intracellular oxygen measurements (26), macrophage intracellular pH measurements (27), 
chloride ion measurements in aqueous solution (61), and a urease-based sensor for urea 
measurements (in manuscript).   
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CHAPTER II:  EXPERIMENTAL  
 
This chapter describes the general experimental information, which includes materials, 
reagents, instrumentation primarily used for the research, and the cell culture work that is 
described within this dissertation. The specific and detailed experimental procedures that pertain 
to any single application will be discussed in the appropriate chapter.  
 
2.1 Material and Reagents 
[9] mercuracarborand-3 (MC-3) was obtained from the laboratory of Dr. Eric Bakker of 
Auburn University. A 10% (solid percentage) suspension of polystyrene particles with an 
average diameter of 0.78 µm (± 3.8% variation), a 10% (solid percentage) suspension of 
carboxyl modified silica microspheres, averaging 1.7 ± 3% µm in diameter, and a 1% (solid 
percentage) suspension of streptavidin coated microspheres, averaging 0.12 ± 10% µm were 
obtained from Bangs Laboratory, Inc. (Fishers, IN). Lucigenin (bis-N-methylacridinium nitrate) 
and 5-((N-(5-(N-(6-(biotinoyl) amino) hexanoyl) amino) pentyl) thioureidyl) fluorescein 
(fluorescein biotin) were obtained from Molecular Probes (Eugene, OR). Flubida-2 was 
purchased from Biotium Inc. (Hayward, CA). Tat peptide was synthesized by Invitrogen Inc. 
(Carlsbad, CA). Dulbecco’s modified Eagle’s medium, Dulbecco’s PBS buffer, Fetal bovine 
serum, Trypsin, L-glutamine, and sodium pyruvate were purchased from Invitrogen Inc. 
(Carlsbad, CA) Human breast cancer cell line (MCF-7) and Hela cell line were purchased from 
American Type Culture Collection (ATCC). Lab-Tek II chambered coverglass was purchased 
from Fisher Scientific. 1, 2-dimyristoyl-sn-glycero-3-phosphate (monosodium salt) (DMPA) and 
1-palmitoyllysophosphatidyl ethanolamine was purchased from Avantilipids (Alabaster, AL). 
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Dihexadecyl phosphate (DP), sodium hexadecanesulfonate, sodium chloride, sodium bromide, 
sodium thiocyanate, sodium iodide Fluorescein-5-thiosemicarbazide (F-NH2), N-
hydroxysuccinimide, N, N’-dicyclohexylcarbodiimide, sebacoyl chloride, sodium bicarbonate, 
triethylamine, sodium hydroxide, hydrogen chloride acid, 4-dimethylaminopyridine, 
ethylenediaminetertaacetic acid disodium salt dehydrate (EDTA), urease (45,000U /g), Bovine 
Serum Albumin (BSA), poly-L-lysine and D-biotin were purchased from Sigma-Aldrich (St. 
Louis, MO). 5,10,15,20-Tetraphenyl-21H,23H-porphine manganese(III) chloride (Chloride 
ionophore I) and the sodium ionophore 4-tert-Butylcalix[4]arene-tetraacetic acid tetraethyl ester 
(sodium iononphore X) were purchased from Fluka (Ronkonkoma, NY).  Buffer solutions were 
prepared from sodium hydroxide and either 3-morpholinopropanesulfonic acid (MOPS), or 
sodium phosphate monobasic, which were purchased from Sigma-Aldrich (St. Louis, MO).  All 
aqueous solutions were prepared with 18 MΩ deionized water produced by a water purification 
system (Barnstead Thermolyne nanopure) and all chemicals were used as received without 
further purification. 
 
2.2 Optical Measurement Instrumentation 
 2.2.1 Spectrofluorometer 
The spectrofluorometer is one of the major instruments used in fluorescence applications. 
The light source of the fluorometer transmits the selected wavelength to the sample, which then 
emits fluorescence. The emitted fluorescence intensity is directly proportional to the sample 
concentration. The fluorometer spectra are presented as intensity vs. wavelength. For a set of 
known standards, the maximum fluorescence intensity at a given wavelength is regressed with 
the known concentration. The resultant linear relationship is used for samples where the 
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fluorescence intensity obtained from the spectra will correspond directly to the sample’s 
concentration. 
In our department we have two spectrofluorometers. One is PTI model QM-1 
spectrofluorometer (PTI, Quantamaster, Ontario, Canada); the other one is LS 55 Luminescence 
spectrometer (Perkin Elmer, USA) which is relatively new and more accurate. Compared to the 
PTI model spectrofluometer, the LS 55 spectrometer is smaller and more compact. All of the 
optical components are under the same cover in contrast to the PTI which is multicomponent. 
The monochromatic slits are automatic and do not need to be changed manually. This important 
aspect increases the accuracy of the instrument. The instrument can change from a liquid sample 
to solid sample holder easily, which increases the versatility and application ability of the 
spectrometer. However, even though the spectrometer’s response and accuracy are improved, the 
major components that make up a spectrometer do not fundamentally change. The major 
components include a light source, monochromators, and a photomultiplier tube (PMT) detector.  
(a)   Light Source 
Both spectrometers, the PTI (not shown) and the Perkin Elmer, use a 75 W xenon (Xe) 
lamp. The lamp supplies a continuous light output from 250 to 700 nm, thus covering both the 
ultraviolet and the visible region of the spectrum. The lamp consists of two electrodes sealed 
under high pressure in a quartz bulb with Xe gas. When the power is turned on, a high voltage 
pulse is generated between the two electrodes, which will induce collisions between the Xe gas. 
The collisions ionize the Xe atoms by removing electrons. The recombination of the removed 
electrons with the ionized Xe atoms will result in a continuum of light.  
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(b)    Monochromators 
The purpose of the monochromator is to disperse a bunch of light into various colors of 
wavelengths. The spectrofluorometer has two monochromators; one is to select an excitation 
wavelength while the other is to select an emission wavelength 
(c)   Photomultiplier tube (PMT) 
The purpose of the photomultiplier tube (PMT) is to amplify electrons, derived from 
incident photons entering the photomultiplier, to an extremely large number of electrons, thus 
increasing the analyte response many times fold. Photomultiplier tubes are used as the detector 
for most types of spectrofluorometers. A PMT output is taken as a current source by the 
instrument and the light intensity emitted by the analyte is proportional to the current, which is 
used to correlate concentration to fluorescence intensity. 
 Figure 2.1 illustrates the principle of photomultiplier tubes. Within the PMT vacuum 
area is a photocathode and a series of dynodes. Incident photons hit the surface of the 
photocathode where an electron will be ejected. The potential difference between the 
photocathode and dynode will accelerate the ejected electrons to the first dynode. Several 
additional electrons are ejected by the differential potential. This process continues along the 
dynode chain, where more electrons are ejected and collected.  When a new current pulse arrives 
at the cathode, a new cycle of this process is started again. By this process, amplification of the 
electrons is generated that represents amplification of the incident signal. 
The PTI spectrofluorometer specifically utilizes digital photon counting detector with a 
discriminator and high-voltage power supply. At constant high voltage, the PMT is very 
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sensitive. The measurement is performed when each photon hits the photocathode of the 
photomultiplier tube. Individual photon results in a count at the anode which can be detected. 
The light hitting on the photomultiplier detector is proportional to the count rate which is the 
number of counts per second.  The detector is usually operated with a discriminator to 
discriminate a low level noise signal from a higher level signal from the incident photons. 
Radiation
     hv
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dynodes
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electrons
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   500-2000V
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current-to-voltage
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Figure 2.1. Schematic of a Photomultiplyer Tube. 
 
2.2.2 Multidetection Microplate Reader 
The design and function of the SpectraMax M2 microplate reader (Molecular Device, 
Inc.) performs similarly to a spetrofluorometer.  However, this is the only system that can 
provide both dual-mode measurement for a cuvette port and 6-384 microplate reading. The major 
components of a multidetection microplate reader are similar to the spectrofluorometer such as 
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the light source, the monochromator, and the photodetector. There is slight difference between 
the two such as the light source for the microplate reader uses a 50 watt xenon flash lamp (versus 
a 75 W for the spectrofluorometer). It has very similar functions for the monochromator. The 
dual monochromators of the microplate reader are flexible to select any absorbance wavelength 
range between 200-1000 nm, any excitation wavelength between 250-850 nm and any emission 
wavelength from 360 to 850 nm. 
The multidetection microplate reader can measure and obtain endpoint and kinetic 
spectra, and multi-point well-scanning for fluorescence and absorbance. It can be applied to the 
field of biochemistry, cell biology, immunology, nuclear biology and microbiology. A schematic 
diagram of the multidetection microplate reader is shown in Figure 2.2. 
 
2.2.3 Digital Fluorescence Microscopy 
Digital fluorescence imaging microscopy system is highly sensitive enable of single 
molecule observation, and specific tool for fluorescent measurement. It can distribute to a single 
molecule measurement and visualize specific fluorescent molecules in intracellular locations. 
Primarily used instrument in the research work is inverted fluorescence microscopy (Olympus 
IX-70). Figure 2.3 illustrates a typical digital fluorescence microscope used in this dissertation. 
The major components in a microscope are the light source, filter cubes, objectives and grating, 
and a charge-coupled device (CCD), which are individually described next. 
1. Light Source 
The fluorescence microscope is a very sensitive instrument that requires a bright, white light 
source. A 100 watt mercury arc lamp is the most commonly used light source. This type of 
lamp provides a bright, continuous emission across the visible range from 400 to 750 nm, 
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plus a UV range of 200 to 399 nm. Mercury lamps also have very distinct and sharp emission 
lines that are very importantly used to characterize the mercury arc lamp and calibrate the 
spectra.  
 
 
 
 
 
 
http://www.moleculardevices.com/pages/instruments/spectramax_m2.html
 
Figure 2.2. Diagram of the Spectramax Microplate reader. 
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Figure 2.3. Diagram of a typical digital fluorescence microscope. 
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2. Filter Cube 
To deliver the light to the specimen from the lamp, then collect the emitting fluorescence and 
form a fluorescence image, the proper filter cube need to be selected. A filter cube is 
typically made up of an excitation filter, a dichromic mirror, and an emission filter. The 
excitation filter is used to excite the specimen by selectively transmitting a narrow band of 
wavelengths. The dichromic mirror is used to reflect the excited light to the specimen and to 
transport the collected emission to the CCD detector. The emission filter is used to transmit 
the emission fluorescence from the specimen and block the residual excited light. Figure 2.4 
illustrates the filter cube components. 
 
 
 
http://www.olympusmicro.com/primer/techniques/fluorescence/filters.html 
Figure 2.4. Filter cube and its components 
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3. Objectives and Grating 
The objective is often considered the most important part of the microscope because the 
image qualities are produced by it. The objective is positioned between the specimen and the 
filter cube. Its function is to transmit the fluorescence inducing light (excitation wavelength) 
to the specimen from the dichromic mirror while allowing passage of the emitted 
fluorescence to the CCD camera for images or spectra. In the lab, we have 10x, 20x, and 40x 
objectives with a numerical aperature of 0.5 or 0.9. 
The diffraction grating is used to separate the mercury light into individual wavelengths 
and can be used as a monochromator and as a spectrograph in microscopy. In one of our 
microscopes, we use a triple grating to achieve efficiency light throughput over a broad 
spectral region, which is equipped with 150 blz (blaze), 300 blz at an optimum wavelength 
(Acton Research, Inc.). 
4. Charged Couple Device (CCD) 
A charged couple device (CCD) is a photon detector used in digital CCD cameras. It is 
made up of thousands, or millions, of pixels, which are silicone diode photosensors. Pixels 
can store information from incident photons that are used to comprise the microscope image. 
Pixels are semiconductor materials that can trap and hold photon-induced electrons 
(photoelectrons) derived from incident photons. A pixel is coupled to a charge storage region 
that will accumulate and store the photoelectrons. This storage region is connected to one 
amplifier that reads out the amount of accumulated charge. The stored charge is transferred 
through the parallel registers to a linear serial register and then to an output mode adjacent to 
the read-out amplifier. 
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The three types of CCD designs are full-frame CCD, frame-transfer CCD, and interline 
transfer CCD. Figure 2.5 illustrates two types of charge-coupled device architectures, namely 
frame-transfer CCD and interline transfer CCD. 
(a) Full-frame CCD 
One of our microscope uses full-frame CCD which is supplied by Andor Tehcnology, 
Inc. In this design, every pixel of the CCD surfaces corresponds to the image being collected. 
During image collection, exposures are usually controlled by an electrochemical shutter. 
(b) Frame-transfer CCD 
In this design, one half of the CCD chip is masked and used as a storage space. After 
exposure, all of the pixels in the image side are transferred to pixels on the storage side. No 
camera shutter is needed because transferring time for the image is only a fraction of the 
exposure time. 
(c)  Interline Transfer CCD 
In this design, imaging rows and masked storage transfer rows are parallel pixels of 
columns. Camcorders and video cameras typically use interline transfer CCDs because they 
provide high quality images and can be read out at video rate. This type of CCD can be used 
for dim fluorescent specimens because of the low camera read noise and improvement in 
camera electronics. Interline transfer CCDs can be very fast and they do not require a shutter 
to control the exposure. With current technologies, the spatial resolution and light-collecting 
efficiency can reach those of a full-frame CCD. 
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http://www.olympusmicro.com/primer/digitalimaging/digitalimagingdetectors.html 
 
Figure 2.5. Frame transfer CCD and Interline transfer CCD. 
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2.3 Cell Culture of Hela and MCF7 Cells 
MCF 7 cell  is one type of breast cancer cells isolated from female and Hela cell is one 
type of cancer cellines isolated from female. These two cancer cells were used in the cell 
delivery experiments. An in-house protocol, developed by Dr. Nitsa Rosenzweig, was used to 
maintain these two different types of cell cultures. MCF 7 cells are cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) (Invitrogen Incorporate, Carlsbad, California) with 10% fetal 
bovine serum, 2 mM antibiotic-antimycotic, 8 mM L-glutamine, and 0.1 mM non-essential 
amino acids. Hela cells are cultured in Minimum Essential Medium (MEM) (Invitrogen. 
Incorporate, Carlsbad, California) with 10% fetal bovine serum, 2% antibiotic-antimycotic, 4 
mM L-glutamine, and 1 mM sodium pyruvate. The cells are grown at 370 C under 5% CO2. The 
medium was changed when there was a lot of cellular debris accumulating, when the medium 
changed color, or in general after two days have past. 
Cell cultures were planted in a 4 well chamber. The following procedures describe the 
cell preparation steps of splitting the cells, counting the cells, and planting the cells.  
To split the cells, the cells are detached from the surface of a T75 tissue culture bottle by 
adding 2 mL of trypsin. The trypsin treated bottle was then placed into an incubator for 10 min. 
The trypsin treated T75 bottle was then removed from the incubator and 20 mL of growth 
medium was added. The cells were mixed with the growth medium by a glass pipette. 
To count the cells, it is always best to count right after splitting them. 500 µL of the cell 
suspension solution was mixed with 0.5 mL of trypan blue in a 1 mL Eppendorf tube. 12 µL of 
the mixed solution was then injected into the hemacytometer. The hemacytometer was then 
placed under the microscope to observe the 9 squares. If the cells number counting on the 
hemacytometer are #a, the number of the cells/mL are calculated by #a multiplying by 20,000. 
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From the calculated number of cells/mL the cells can be plated. The number of cells/well 
needed is known, then to determine how much volume in mL of the cell suspension is needed to 
add to each plate. For a 4 chamber well plate, we add 0.15 mL of the cell suspension (~1×106 
cells/mL) to each well, and 0.7 mL of growth medium. The cells are incubated to attach and 
grow onto the wells at 370 C under 5% CO2. Typically 70-90% confluency is achieved in one 
day for Hela cells or 3 days for MCF7 cells. 
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CHAPTER III   SUBMICROMETRIC LIPOBEAD-BASED FLUORESCENCE 
SENSORS FOR CHLORIDE ION MEASUREMENTS IN AQUEOUS SOLUTION 
 
3.1 Introduction 
Chloride is one of the major anions in biological fluids.  A number of physiological 
mechanisms that regulate cellular physiochemical properties like cell volume and pH, as well as 
membrane transport properties, involve chloride ion transport across cell membranes.  An 
example of the importance of chloride ion transport is found in the disease Cystic Fibrosis where 
a defective transport of chloride anions across the plasma membrane of epithelial cells is often 
observed (1).  A number of techniques have been used to detect chloride anions in biological 
systems.  These include colorimetric titration (2), patch-clamp (3, 4), microelectrode (5, 6), fiber 
optic chloride ion sensor (7 Kopelman) and x-ray microanalysis (7).  These approaches are 
invasive and generally lack sufficient sensitivity and selectivity.  There is a need for less invasive 
and more sensitive methods for anion detection in biological systems. 
Molecular fluorescence probes have emerged in the last two decades as useful tools for 
ion analysis in biological fluids.  Most of the fluorescence probes were developed for the 
measurement of pH, and cations in cells (8, 9).  Recently, these and other molecular fluorescence 
probes were immobilized to particles that were used as intracellular sensors.  These particles 
include PEBBLEs (probes encapculated by biologically localized embedding) (10), liposomes 
(11-13), and lipobeads (14-16).  Currently developed by Kopelman and co-workers PEBBLEs 
consist of a hydrophilic polymer matrix, e.g. polyacrylamide, which contains various 
fluorescence indicators.  PEBBLEs have shown to be highly selective and sensitive. Due to their 
nanometric dimensions they exhibit fast response times in the millisecond time scale.  Liposome-
based sensors enable the encapsulation of hydrophilic and hydrophobic indicators in their 
 29 
 
membranes and exhibit high biocompatibility (17-20).  However, high leakage rate of 
fluorophores from liposomes is often observed, which negatively affect their analytical sensing 
properties (21).  In our laboratory, we recently developed a new type of particle-based 
nanosensors termed lipobeads.  Lipobeads are submicrometric polystyrene nanoparticles that are 
coated with a phospholipid membrane.  Hydrophilic or hydrophobic fluorescent indicators can be 
immobilized to the phospholipid membrane (14-16, 22, 23).  Previously we showed that 
lipobead-based fluorescence sensors could be used for intracellular pH and oxygen sensing under 
physiological conditions.  Other groups have studied similar nanosensors termed lipospheres (24-
27).  Lipospheres consist of a hydrophobic fat core that is coated with a monolayer of 
phospholipids (28).  While formulations of lipobeads show consistency in diameter and narrow 
size distribution it is more difficult to control the particle size and size distribution of 
lipospheres.  Often, a heterogeneous sample of lipospheres ranging between 0.2 and 500 µm is 
obtained.  Both lipobeads and lipospheres have similar advantages such as high physical 
stability, and low leakage rate of encapsulated probes and drugs.  They are particularly attractive 
when hydrophobic indicators are used as sensing probes.   
This paper reports the synthesis, characterization, and optimization of fluorescence-based 
submicrometric chloride ion sensing lipobeads.  A unique chemistry is used in their design, 
which enables for the first time stable non-covalent immobilization of hydrophilic sensing dyes 
in their membrane. 
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3.2 Experimental 
3.2.1 Preparation of Lucigenin- Hexadecanesulfonate Ion Pairs 
The lucigenin- hexadecanesulfonate ion pair was synthesized following a method 
previously described by Wolbeis et al (29) with slight modifications. 2.6 mg lucigenin were 
dissolved in 4 mL phosphate buffer at pH 7.0.  3.3 mg of sodium hexadecanesulfonate dissolved 
in 2 mL methanol were added to the buffer solution.  The resulting mixture was incubated at 
room temperature for 1 hour.  The formed lucigenin- hexadecanesulfonate ion pair was then 
extracted with 15 mL chloroform.  The chloroform solution was reduced to dryness by a gentle 
stream of nitrogen.  The lucigenin-hexadecanesulfonate ion pair was then reconstituted in 0.5 mL 
chloroform resulting in a 10 mM lucigenin- hexadecanesulfonate solution. 
 
3.2.2 Synthesis of Nanometric Fluorescent Lipobeads 
The synthesis of the lipobeads was carried out using an oil-in-water microemulsion 
method.  A 50 mM lipid stock solution was prepared with a 9:1 molar ratio mixture of 1,2-
dimyristoyl-sn-glycero-3-phosphate (monosodium salt) (DMPA) and dihexadecyl phosphate 
(DP) in chloroform/methanol/H2O (65:25:4 v/v/v).  Microemulsion was formed when 90 µL of 
the phospholipid solution and 30 µL of the 10 mM lucigenin- hexadecanesulfonate ion pair 
dissolved in chloroform were added to 100 µL aqueous suspension of polystyrene microspheres 
averaging 780 ± 3.8% nm in diameter.  The microemulsion was transferred to a 50 mL round 
bottomed flask in which the mixture was evaporated by a rotary evaporator.  The microemulsion 
had to be dried completely to avoid subsequent aggregation of the lipobeads.  The dried 
lipobeads sample was then resuspended in 5 mL of MOPS buffer at pH 7.4 and gently stirred for 
5 hours.  The formed lipobeads were washed three times using slow speed centrifugation (4000 
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rpm for 15 minutes) to remove excess fluorescent indicator and phospholipid molecules and 
unreacted polystyrene microspheres.  Lipobeads coupled with indicators were suspended in 10 
mL of MOPS buffer (pH 7.4) and stored in glass vials covered with aluminum foil at 4 0C until 
used. 
 
3.2.3 Incorporation and Comparison of Ionophores 
The ionophores [9] mercuracarborand-3 (MC-3), the manganese based ionophore 
5,10,15,20-Tetraphenyl-21H, 23H-porphine manganese (III) chloride (Chloride Ionophore I), 
and the sodium ionophore 4-tert-Butylcalix [4] arene-tetraacetic acid tetraethyl ester (Sodium 
Ionophore X), were each incorporated into the lipobeads for ion response comparative studies. 
The hydrophobic ionophores were easily incorporated into the phospholipid membrane by 
adding the ionophores to the phospholipid solution used for the preparation of the lipobeads.  
The lipobeads containing the three ionophores were tested for their response to millimolar 
concentrations of Cl-, Br-, I-, and NCS- using a Photon Technologies Inc. fluorimeter (PTI, 
Canada).  For calibrating the chloride ion sensitive lipobeads, 1 mL lipobeads suspension was 
placed in a cuvette and its emission at 500 nm (ex = 430 nm) was measured using the 
spectrofluorometer.  Under constant stirring, microliter aliquots of 1 M NaCl in a MOPS buffer 
solution at pH 7.4 were added to the cuvette to obtain increasing concentrations of chloride ions.  
Each data point was repeated three times. 
 
3.2.4 Response Time of the MC-3 Lipobeads 
The response time of the MC-3 lipobeads was measured by monitoring the change in 
fluorescence intensity upon the addition of a chloride solution to a solution of the chloride 
sensing lipobeads suspended in a phosphate buffer solution at pH 7.0.  The fluorescence intensity 
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was measured as a function of time using excitation wavelength of 430 nm and an emission 
wavelength of 500 nm.  To conduct the measurement 1.8 mL of lipobead solution was placed in 
a 3 mL quartz cuvette (1 cm pathlength).  The sample was placed in the fluorometer and its 
emission was monitored until obtaining a stable baseline. Then, 10 µL of a 3 M NaCl solution 
was injected into the cuvette while the lipobead solution was stirred.  The emission measurement 
was continuously recorded until a stable baseline was observed.  
 
3.2.5 Digital Fluorescence-Imaging Microscopy 
The experimental setup used for fluorescence measurements of the lipobeads based 
sensors consisted of an inverted fluorescence microscope (Olympus IX-51) that is attached to a 
high performance charge coupled device (CCD) camera (Andor Technology, DV434-BV). A 
100-W mercury lamp was used as the light source for excitation. The fluorescence was collected 
through a 40X microscope objective with N.A=0.9.  A filter cube containing suitable excitation 
filters, dichroic mirrors, and emission filters was used to ensure spectral purity. The exposure 
time used in most experiment was 0.5 seconds.  The software Image Pro+ (Media cybernetics 
inc.) was used for image analysis. 
 
3.3 RESULTS AND DISCUSSION 
 
3.3.1 Choice of Fluorescence Indicator 
A number of fluorescent indicators were used previously for chloride ion analysis in aqueous 
samples (30). Table 3.1 is a compilation of the spectroscopic properties of widely used Cl- 
sensitive chromophores (monique) (31).  For our lipobead based sensors we chose lucigenin 
(N,N’-dimethyl-9,9’-bisacridinium dinitrate), as the chloride sensitive fluorophore.  Lucigenin is 
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a heterocyclic compound with quaternized nitrogen atoms that is highly sensitive to chloride 
quenching. Figue 3.1 illustrates the lucigenin structure (32).  Its maximum excitation and 
emission wavelengths (λex = 430 nm, λem = 500 nm) are longer than the excitation and 
emission wavelengths of other chloride ion fluorescence indicators like 6-methoxy-N-(3-
sulfopropyl) quinolinium (SPQ) (33).  Lucigenin is characterized by a relatively high emission 
quantum yield of 0.67 and it is pH insensitive between pH 5 and 8 (34).  Its fluorescence is 
minimally quenched by inorganic anions like sulfate, nitrate and phosphate, organic anions like 
bicarbonate and citrate, and monovalent and divalent cations that are abundant in biological 
fluids (33). Figure 3.2(a) shows the fluorescence quenching response of free lucigenin in 
solutions of increasing chloride ion concentrations.  The fluorescence intensity at 490 nm 
(λex=430 nm) decreases by approximately 10 fold as the chloride ion concentration increases 
from 0 to 50 mM. Figure 3.2(b) shows a Stern-Volmer plot describing the chloride ion 
concentration dependence of the ratio F0/F of free lucigenin, where F0 is the fluorescence 
intensity at chloride free solution while F is the fluorescence intensity at a given chloride ion 
concentration. The Stern-Volmer quenching constant, Ksv, was determined to be 225 M-1, with a 
correlation coefficient of 0.9945. 
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 Absorbance   Fluorescence   
 Peak abs 
(nm) 
Molar extinct. 
coeff. 
(M-1 cm-1) 
Excitation
(nm) 
Emission 
(nm) 
Quantum 
yield 
Khalide
(M-1) 
SPQ 318/345 5,400/3,450 322/350 450 0.69 118 (Cl-1)
MEQ 318/344 5,700/4,100 322/350 440 0.70 140 (Cl-1)
MQAE 320/350 4,850/2,800 355 460 0.75 200 (Cl-1)
TMAPQ 318/348 5,800/3,700 325/355 450 0.73 310 (Cl-1)
Lucigenin 368/455 34,200/7,400 368/455 506 0.67 390 
LMQ 428 9000 428 533 0.47 70 (Cl-1) 
Bis-
DMXPQ 
324/342/ 
440 
36,200/26,800/ 
7,000 
342/364/ 
440 
450/560 0.40 
(450 nm) 
0.04 
(560 nm) 
82 (Cl-1) 
 
SPQ: N-sulfopropyl-quinolinium; MEQ: 6-methoxy-N-ethylquinolinium iodide; MQAE: N-
(ethoxycarbonylmethyl)-6- methoxyquinolinium bromide; TMAPQ: 6-Methoxy-N-93-
trimethylammoniumpropyl)quinolimium dibromide; Lucigenin: N,N`-Dimethyl-9,9`-
biacridinium dinitrate; LMQ: 4-aminopyrido[2,1-h]-Pteridin-11-ium-5-olate; Bis-DMXPQ: 
trans-1,2-bis[4-(1- '-MQ-1'- '-DMAQ-xylyl)-pyridinium] ethylene 
 
Table 3.1. Properties of chloride indicators. 
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Figure 3.1. Lucigenin structure. 
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Figure 3.2 -(a) Fluorescence spectra of lucigenin in phosphate buffer solutions at pH 7.4 with 
increasing chloride ion concentrations from 0 to 50 mM (λex=430 nm) (b) A Stern-Volmer plot 
describing the ratio between the initial fluorescence (F0) intensity and the fluorescence intensity 
at a given chloride ion concentration (F) against chloride ion concentration.  The Stern-Volmer 
constant, Ksv, was determined to be 225 M-1.  
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3.3.2 Incorporation of Ion-Pair into the lipobeads 
Lipobeads that only contain lucigenin were ineffective as chloride ion sensors due to poor 
partition of the water-soluble lucigenin molecules into the phospholipid membrane and high 
leakage rate of the immobilized lucigenin molecules to the aqueous medium.  To stabilize the 
chloride ion sensing lipobeads, hexadecanesulfonate molecules were co-immobilized into the 
phospholipid membrane.  Scheme 3.1 illustrates the formation of the ion pair between lucigenin 
and hexadecansulfonate.   The negatively charged hexadecanesulfonate molecules are attracted 
electrostatically to the positively charged nitrogen atoms of the lucigenin molecules.  The 
complex becomes more hydrophobic and could partition into the phospholipid membrane at a 
higher rate compared to the partition of free lucigenin molecules.  To determine if the 
incorporation of the ion pair would have a detrimental effect on the luminescence properties of 
lucigenin we compared the absorbance and emission spectra of lucigenin dissolved in aqueous 
solution and lucigenin-hexadecanesulfonate ion pair dissolved in chloroform.  Figure 3.2 shows 
that the formation of the lucigenin-hexadecanesulfonate ion pair had minimal effect on the 
absorption and fluorescence of lucigenin.  The shape of the absorption spectrum remained 
similar except for an increased absorption between 400 and 450 nm (figure 3.3a).  The 
fluorescence spectrum (figure 3.3b) shows no apparent shifts or change in peak shape except for 
minor features at 470 nm.  Digital fluorescence images of lipobeads containing free lucigenin 
and lucigenin-hexadecanesulfonate ion  
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Scheme 3.1 - A proposed mechanism for the incorporation of the ion-pair into the phospholipid 
membrane.  The lucigenin molecules partition effectively into the phospholipid membrane due to 
the formation of ion pairs with hexadecanesulfonate.  
 
 
pairs are shown in figures 3.4a and 3.4b respectively.  Both images reveal that the lipobeads 
were monodispered in aqueous solution.  However, the lipobeads that contain lucigenin-
hexadecanesulfonate appear brighter than lipobeads that contain free lucigenin.  To quantify the 
difference in brightness we measured the signal to background ratio in these images. 
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Figure 3.3 - Absorption spectra (a) and fluorescence spectra (b) comparing the spectroscopic 
properties of free lucigenin in aqueous solution and the lucigenin- hexadecanesulfonate ion pair 
dissolved in chloroform.  The ion pair formation had minimal effect on the spectroscopic 
properties of lucigenin.   
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We first defined the boundaries of the particles and measured their fluorescence intensity.  We 
then measured the background signal by defining areas near the measured particles that occupied 
the same number of pixels and measured the fluorescence intensity of these areas.  The average 
signal to background ratio in figure 3.4b (lucigenin-hexadecanesulfonate lipobeads) is about 100 
while the signal to background ratio in figure 3.4a is about 13 (free lucigenin lipobeads).  It is 
fair to conclude that the formation of ion pairs between hexadecanesulfonate and lucigenin 
decreased the hydrophillicity of the dye and increased its partition rate into the membrane.  This 
resulted in a largely increased brightness of the particles.  We also characterized the effect of ion 
pair formation on the leaking stability of the chloride ion sensing lipobeads. A lipobeads sample 
suspended in 10 ml MOPS buffer solution at pH 7.4.  The particles were precipitated daily using 
slow speed centrifugation (4000 rpm for 15 minutes) and the fluorescence of the supernatant was 
measured to test for leakage of fluorophores from the membrane of the particles.  No significant 
leakage was observed over a period of two weeks.  In contrast, lipobeads containing free 
lucigenin were largely unstable loosing over 50% of their fluorescence during the first 24 hours 
of storage.  We concluded that the formation of the lucigenin- hexadecanesulfonate ion pairs 
largely increased the leakage stability of the lipobeads.  We also tested the photobleaching rate of 
the lucigenin containing lipobeads.  Lipobeads samples were placed on a microscope slide and 
were illuminated constantly for 30 minutes using the 100W mercury lamp of the microscope.  
We found that the excitation intensity must be reduced to minimize photobleaching of the 
particles.  Using a neutral density filter of 1.0 we found that the fluorescence of the lipobeads 
lost less than 10% of the original fluorescence signal during 
 
 
 41 
 
 (a) 
 
 
 
 
 
 
 
 
 
 
 (b) 
 
 
 
 
 
 
 
 
 
Figure 3.4 - Digital fluorescence images of (a) lipobeads containing free lucigenin, (b) lipobeads 
containing the lucigenin- hexadecanesulfonate ion pair.  The signal to background ratio improves 
from 13 (image 3.4a) to about 100 (image 3.4b). 
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30 minutes of continuous illumination.  It should be noted that in microscopy experiments the 
lipobeads are exposed to excitation light only during the actual exposure time of the CCD 
camera used for imaging.  In a typical experiment the lipobeads are exposed to the excitation 
light for less than 1 minute. 
 
3.3.3 A Comparison Between Ionophores 
To further improve the selectivity of the lipobeads, ionophores (34) were incorporated 
into the phospholipid membrane of the lipobeads.  Due to their inherent hydrophobicity, the 
ionophores used in this study were easily incorporated into the phospholipid membrane, simply 
by adding the ionophores to the phospholipid cocktail used in the microemulsion.  Figure 3.5 
illustrates the transport mechanism of the analyte by the ionophore into the lipobeads membrane.  
In our experiments we compared the performance of three ionophores.  [9] mercuracarborand-3 
(MC-3)(35-37) and the manganese based Chloride Ionophore I are known for their chloride ion 
selectivity (38).  We also utilized the Sodium Ionophore X as an ionophore in our system.  As 
previously mentioned chloride ionophores selectively transport chloride anions into the 
membrane.  This is followed by the permeation of counter cations into the membrane (e.g 
sodium) to balance the membrane charge.  Sodium ionophores transport sodium cations into the 
membrane, which is followed by the permeation of counter anions to balance the membrane 
charge.  It was expected that a membrane containing sodium ionophore would show lower 
selectivity towards chloride ions since all the anions in the analyte solution could permeate the 
membrane following sodium ion transport.  The chloride ion selectivity of this system was based 
on the lucigenin selectivity and on the difference between the permeation rate of chloride 
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Figure 3.5 - Mechanism of the phase transport of chloride ions from the aqueous phase, by the 
ionophore, into the lipobead membrane. Iono+ is the ionophore, Cl- the anion analyte, and 
Iono+Cl- the ionophore:analyte complex.  The ionophore transports the anion from the aqueous 
phase into the phospholipid membrane, thus allowing the chloride to quench the fluorescence of 
lucigenin.  
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ions and other ions into the membrane.  On the other hand, membranes containing chloride 
selective ionophores were expected to show higher chloride ion selectivity since chloride ions 
were selectively transported into the membrane and lucigenin selectively responded to chloride 
ions.  However, some interference from other halides, particularly iodide, was still observed.  It 
should be noted however that in biological fluids the level of chloride is 4 or more orders of 
magnitude higher than the level of other halides.  Our studies revealed that the ionophore MC-3 
was about twice more selective to chloride ions than to other halides and showed 50% lower 
response to iodide. Figure 3.6 shows the structure of the chloride ionophore MC-3.  Both MC-3 
and the chloride ionophore I did not respond to other competing ions like phosphate and 
bicarbonate.  Phospholipid containing MC-3 were slightly more stable than lipobeads containing 
the chloride ionophore I.  We therefore focused our experiments on MC-3 containing lipobeads.  
Figure 3.7 describes the fluorescence response of chloride sensitive lipobeads as a function of 
MC-3 concentration in the lipobeads preparation solution.  The chloride ion response is defined 
as F0/F50mM where F0 is the fluorescence intensity of the lipobeads in a chloride free MOPS 
buffer solution at pH 7.4, and F50mM is the fluorescence intensity of the lipobeads when the 
chloride ion concentration in the same lipobeads solution is raised to 50 mM.  At low 
concentrations MC-3 did not effectively transport chloride ions into the membrane.  The chloride 
ion response of the lipobeads increased with increasing chloride ion concentrations.  The 
lipobeads exhibited the highest chloride ion sensitivity when the concentration of MC-3 in the 
lipobeads preparation solution was about 5 mM. However, the response decreased sharply as the 
concentration of the ionophore exceeded 5 mM.  This is attributed to a 
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Figure 3.6.  Structure of the chloride ionophore MC-3. 
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Figure 3.7 – The chloride response of MC-3 containing lipobeads (F0/F50mM) as afunction of 
MC-3 concentration.  F0 is the fluorescence intensity of MC-3 containing lipobeads in a chloride 
free phosphate buffer solution at pH 7.2.  F50mM is the fluorescence intensity of the lipobeads 
solution when the chloride ion concentration is raised to 50 mM.  It can be seen that the optimal 
MC-3 concentration in the phospholipid solution used to prepare the lipobeads is 5 mM. 
 
 
 competition between the ionophore molecules and the lucigenin- hexadecanesulfonate ion pairs 
on the limited number of hydrophobic pockets in the phospholipid membrane.  Indeed, the 
fluorescence intensity of the lipobeads as well as the chloride ion response decreased with 
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increasing concentrations of MC-3 in the phospholipid solution that was used to prepare the 
lipobeads.   
 
3.3.4 Analytical Properties of the MC-3 Lipobeads 
Figure 3.8 shows a Stern-Volmer plot of chloride sensing lipobeads that contain the 
lucigenin- hexadecanesulfonate ion pair and MC-3 with increasing chloride ion concentrations.  
Similarly to other fluorescence quenching based sensors a significant variation from linearity is 
observed.  This is attributed to heterogeneity in the microenvironment of fluorescence indicators 
within the supportive matrix of solid-state sensors (39,40).  In our system, there are a limited 
number of lucigenin molecules that are stably immobilized to the surface of the phospholipid 
membrane. These molecules are more accessible to chloride ions than lucigenin ion pairs that are 
embedded in the hydrophobic region of the phospholipid membrane.  As a result, the Stern 
Volmer constant, Ksv, at chloride ion concentrations below 2 mM is higher than Ksv at higher 
concentrations.  Furthermore, additional variation from linearity is observed at concentrations 
higher than 30 mM due to saturation.  The change in Ksv values is clearly seen in Figure 3.8 
where the three concentration zones are characterized by dashed lines of decreasing Ksv.  The Ksv 
between 2 and 50 mM, which the biologically relevant concentration zone, is about 17 M-1, 
which is an order of magnitude lower than the Stern-Volmer constant of free lucigenin in 
solution.  This is typically observed in solid-state sensors since the analyte of interest must 
permeate through the solid-state support, in our case the phospholipid membrane, to interact with 
the sensing fluorophores.  Nevertheless, the chloride ion sensitivity of the chloride sensing 
lipobeads is sufficient to quantify chloride ion levels often found in the millimolar range in 
biological fluids. 
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Figure 3.8 - A Stern-Volmer plot describing the chloride ion response F0/F with increasing 
chloride ion concentrations.  F0 is the fluorescence intensity of the lipobeads in a chloride free 
phosphate buffer solution at pH 7.2.  F is the fluorescence intensity of the lipobead solution at a 
given chloride ion concentration.  Typical variations from linearity are observed at chloride ion 
concentrations lower than 2 mM and higher than 30 mM. 
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Previous studies in our laboratory with oxygen sensing lipobeads showed that the response time 
of individual lipobeads was in the sub-second time scale. However, oxygen readily permeates 
through the phospholipid membrane of the lipobeads while chloride ions, as previously 
discussed, require an active transport mechanism by an ionophore to effectively interact with the 
sensing fluorophore.  Response time measurements of the chloride sensing lipobeads are shown 
in figure 3.9.  The fluorescence of a lipobeads solution was measured using the fluorometer at 
500 nm (λex = 430 nm).  The fluorescence dropped sharply when an aliquot of concentrated 
chloride solution was injected into the constantly stirred lipobeads solution.  Since each data 
point represents a time interval of 1 second the response time could be estimated to be about 5 
seconds.  It was difficult to obtain the recovery time of the lipobeads since diluting the sample 
with an aqueous sample diluted the number of lipobeads in the sample and decreased the 
fluorescence intensity of the solution.  Adding aqueous solution containing lipobeads at the 
original lipobeads concentration was problematic as well since such injection often resulted in an 
intensity spike due to light scattering.  Full reversibility studies would require immobilization of 
the lipobeads to a solid-state support (e.g. glass).  A procedure to immobilize the fluorescence 
sensing lipobeads to a glass support through silane chemistry is currently developed in our 
laboratory.  
 
3.4 CONCLUSIONS 
This paper reports the development of unique chloride ion sensing lipobeads of 
submicrometric dimensions with the capability to quantify chloride ion levels in aqueous 
samples and biological fluids.  Several new advances are reported: First, the use for the first time  
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Figure 3.9 - Characterization of the response time of the chloride ion sensing lipobeads- the 
fluorescence intensity of the lipobeads prior and following the injection of an aliquot of 
concentrated chloride solution is shown. 
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of an oil-in-water microemulsion method to prepare the lipobeads resulted in lipobead 
formulations of smaller lipobead diameters with minimal aggregation compared to previous 
studies in our laboratory and compared to other submicrometric particle-based sensors.  
Secondly, the paper describes the first lipobead based anion sensor.  To realize this task the 
naturally hydrophilic chloride sensitive dye lucigenin was ion paired with alkyl 
hexadecanesulfonate to decrease its hydrophilicity.  This resulted in greater partition rate of the 
lucigenin dye into the membrane of the lipobeads and decreased the leakage of lucigenin from 
the sensing particles.  The formation of lucigenin- hexadecanesulfonate ion pairs and their 
incorporation into the phospholipid membrane did not affect the luminescence properties of 
lucigenin.  However, due to poor permeability of chloride into the membrane the lucigenin 
containing lipobeads were ineffective as chloride ion sensors in the absence of an active 
mechanism for chloride ion transport from the solution into the membrane.  The incorporation of 
the chloride ionophore [9] mercuracarborand-3 (MC-3) into the phospholipid membrane 
provided the required transport mechanism.  The chloride sensing technique presented in this 
paper is different than previously described chloride ion sensors that were based on the co-
immobilization of a chloride selective ionophore and a pH sensitive dye in thin films or larger 
particles.  The transport of chloride ions into the film or particles resulted in a proton gradient 
that was sensed by the pH sensitive dye.  Such systems have been limited in their application to 
solutions of strong buffering capacity, as pH changes in the solution would surely elucidate a 
response from the chloride ion sensor.  The use of the chloride sensitive dye lucigenin instead of 
a pH sensitive dye is a departure from this pH based sensing technology.  Moreover, the use of 
lucigenin provides an additional selectivity dimension since both the ionophore MC-3 and 
lucigenin are chloride ion selective.  However, while chloride ionophores are insensitive to 
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biologically important anions like phosphate and bicarbonate there is still a room for 
improvement in their chloride ion selectivity particularly against other halides.  Currently 
available anion selective ionophores are not as effective as cation selective ionophores such as 
the ones available for sodium and calcium.  The development of anion selective ionophores will 
continue to be the bottleneck for the development of anion sensors in the foreseeable future.  
Nevertheless, even with their current analytical properties our newly developed chloride sensing 
lipobeads provide an effective technique for the measurement of chloride ions in biological 
fluids.  
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CHAPTER IV: LIPOBEAD-BASED FLUORESCENCE BIOSENSOR FOR UREA 
 
4.1 INTRODUCTION 
There is a growing interest in the development of optochemical miniaturized sensors with 
the capability to measure minute chemical changes in volume-limited and complex 
microenvironments.  Recently, molecular fluorescence dyes were entrapped in submicrometric 
particles that were used as fluorescence sensors in volume limited samples like single cells.  
PEBBLEs (probes encapsulated by biologically localized embedding) first developed by 
Kopelman and coworkers were composed of a hydrophilic polymer matrix, e.g. polyacrylamide 
with fluorescence indicators copolymerized or physically entrapped in the polymeric matrix 
(1,2).  They show high selectivity, sensitivity and fast response time in the millisecond time 
scale.  In our laboratory, we encapsulated hydrophilic and hydrophobic indicators in 
phospholipids vesicles (liposomes) and employed them as fluorescence sensors (3-6).  However, 
poor stability of liposomes prevented their application as sensors in biological fluids.  Recently 
we prepared an advanced version of liposome-based sensors that was based on the use of 
fluorescent lipobeads.  Lipobeads are polymer particles ranging from 0.2 to 2 µm in diameter 
that are coated with a phospholipid membrane.  The phospholipid membrane could be used to 
immobilize hydrophilic fluorescent indicators through covalent attachment to the phospholipids’ 
head-groups of the membrane.  It could also be used to immobilize hydrophobic fluorescent 
indicators through physical adsorption to the hydrophobic region of the phospholipids membrane 
(7-10).  We showed that fluorescence sensing lipobeads could be used for intracellular pH and 
oxygen measurements (8, 9).  We also developed lipobead-based sensors for chloride ions in 
aqueous samples (10). 
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Previously, lipobead-based sensors were prepared in our laboratory by coating 
polystyrene particles with phospholipids and physically immobilize fluorescent indicators to the 
phospholipid membrane (7-10).  Typically, lipobeads solutions could be stored for up to two 
weeks without substantial loss of activity due to leakage of phospholipids or fluorescent 
molecules to the storage solution.  It was also preferable that a hydrophobic indicator would be 
immobilized to the lipobeads to increase their stability toward leakage.  This limited the scope of 
analytes that could be detected using this sensing technique.  In this paper, we describe a new 
approach for the synthesis of fluorescence sensing lipobeads.  Micrometric carboxyl-modified 
silica particles replaced the polystyrene particles as a supportive core matrix.  Amino-
functionalized phospholipids replaced the non-functionalized phospholipids like 1, 2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) that were previously used to form the 
phospholipid membrane of the lipobeads.  Furthermore, the fluorescent indicators and enzyme 
molecules were attached covalently to the phospholipid membrane.  The resulting new lipobeads 
exhibited higher chemical stability since all the molecular components were attached covalently 
to the sensing particles.   
To demonstrate the capability of the new lipobead based fluorescence sensors we 
developed fluorescence biosensing lipobeads for urea.  Urea has been frequently a target for 
biosensor development since abnormal urea levels in urine are indicative of urinary tract 
infections. Normal urea levels in urine are from 30 to 80 mM (11), and normal urea levels in 
serum are around 6.2 mM (12). High levels of urea in blood are related to renal diseases like pre-
renal azotemia, post-renal azotemia and kidney function abnormalities (13, 14).  A fluorescence 
biosensor for urea was first developed by Guilbault and coworkers as early as 1969 (15).  It was 
based on the co-immobilization of the enzyme urease hydrolase and a fluorescent indicator to a 
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solid-state support.  Urease hydrolase catalyzes the conversion of urea to ammonia, which results 
in a pH increase in the analyte sample. 
          Urease hydrolase 
NH2CONH2 + 2H2O +  H+                                      2NH4+ HCO3-
 
Since then, different types of transducers were applied in urea biosensors to detect increasing pH 
or ammonium ion levels in the presence of urea.  These include chromophores (16), fluorophores 
(17-22), pH and ion selective electrodes in voltammetric (23-25) or amperometric modes (26-
28), and field effect transistors (29).  The performance limiting factor has often been the 
immobilization of the enzyme to the sensing support.  Successful immobilization of enzymes or 
other bioactive molecules leads to minimal loss of activity and increased stability toward 
denaturization.  While efficient immobilization is important for successful fabrication of large 
sensors, it is critical for successful fabrication of micrometric sensors since the number of 
enzyme and fluorescence sensing molecules per sensor is limited.  This paper describes the 
preparation and analytical properties of micrometric sensing lipobeads for urea that were 
prepared using our new covalent approach for lipobead synthesis. 
 
4.2 EXPERIMENTAL  
4.2.1 Synthesis of Silica Lipobead  
Phospholipid coated silica particles (silica lipobeads) were synthesized following a 
method previously developed by Thompson et al (30, 31) for the attachment of phospholipids to 
a glass surface.  The multi step synthesis is shown in schemes 1, 2, and described in the 
following sections: 
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4.2.2 Activation of Carboxylic Surfaces of Silica Microspheres  
0.1 ml of a 10% solution of 1.7 µm silica microspheres were dried under nitrogen.  Then, 
1 ml 0.1 M N-hydroxysuccinimide and 0.1 M N, N’-dicyclohexylcarbodiimide in dimethyl 
formamide (DMF) were added to the dry powder and the suspension was stirred overnight.  The 
activated silica microspheres were washed with DMF by centrifugation at 4000 rpm for 5 min 
and re-suspended in DMF.   
 
4.2.3 Covalent Binding of 1-Palmitoyllysophosphatidyl-ethanolamine to the Silica 
Microspheres 
The activated silica microspheres were esterified with 1 mL 0.02 M 1-
palmitoyllysophosphatidyl-ethanolamine in DMF and 0.4 mL triethylamine. The reaction 
mixture was stirred for 48 hours at room temperature. The resulting modified lipobeads were 
washed with DMF and dried under nitrogen. 
 
4.2.4 Acylation of the sn-2 Hydroxyl of the Immobilized Lipids  
The dried lipobeads were acylated with 1 mL 0.01 M sebacoyl chloride and 0.1 mL 0.1 
M 4-dimethylaminopyridine in tetrahydrofuran (THF) and stirred overnight.  The resulting 
lipobeads were washed with THF and dried under nitrogen. 
 
4.2.5 Conversion of the Terminal Acid Chloride to Acidic Moiety 
1 mL Saturated sodium bicarbonate in a methanol:deionized water (5:1) solution were 
added to the 0.1 mg lipobeads powder. The suspension was incubated for three hours.  The 
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lipobeads solution was washed with deionized water by centrifugation at 4000 rpm and dried 
under nitrogen. 
 
4.2.6 Choice of Fluorescent Indicator 
Fluorescein is the earliest pH probe used in fluorescent microscopy. Fluorescein emits 
fluorescence only in the monoanion and dianion forms. Fluorescein equilibrates with different 
ions at different pH. Above pH 9.0, the phenol and carboxylic function groups of fluorescent 
indicator are totally anized. When we first acidify the aqueous solution, the dianions will convert 
to the monoanion with the phenol function group protonation. The reason why the phenol group 
protonates first because the pKa of phenol is ~ 6.4, while the pKa of the carboxylic acid is less 
than 5.0. When the aqueous solution further acidifies, the monoanion will change to the neutral 
form that is not fluorescent itself. If the fluorophore environment becomes more acidic, it will go 
to the cation form with no fluorescence emitting. If we dissolve the fluorescein in organic solvent 
such as acetone, the fluorescein will form lactone that is not fluorescent at all. Figure 4.1 shows 
the ionization forms of fluorescein. The fluorescent intensity changes demonstrate the 
equilibrium of the monoanion and dianion forms of the fluorescein.  
The specific fluorescein used was fluorescein-5-thiosemicarbazide. Its first pKa is 6.5 and it 
can dissolve in dimethylfloride (DMF) and basic aqueous buffer solution. Figure 4.2 shows the 
structure of this fluorophore (64). In aqueous solution, the excitation and emission of this 
fluorescein-5-thiosemicarbazide is 490 nm and 515 nm, respectively. The advantage of the 
excitation spectrum is to allow ratiometric pH measurement at 450 nm and 490nm due to its long 
excitation wavelength, which will avoid nonuniform dye loading, photobleaching, dye leakage  
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Figure 4.1.  Ionization forms of fluorescein. 
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Figure 4.2.  Structure of Fluorescein-5-thiosemicarbazide. 
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and cell background fluorescence. Fluorescein-5-thiosemicarbazide has a primary amine 
functional group that is convenient to use for covalently binding during synthesis of the bead 
sensing system.  We use this advantage to apply carboxylate cross-linking to the amine to form 
amide and avoid fluorophore leaking from the lipobeads. 
 
4.2.7 Covalent Binding of Urease and Fluorescein-5-thiosemicarbazide to the Lipobeads  
The acylated lipobeads were activated with 1 mL 0.1 M N-hydroxysuccinimide and 1 mL 
0.1 M N, N’- dicyclohexylcarbodiimide in DMF. The activated lipobeads were added to 0.2 mM 
EDTA solution containing 100 µg urease (45,000 U per g) and 500 µL 1 mM fluorescein-5-
thiosemicarbazide at pH 6.0.  The reaction mixture was stirred for 48 hrs at 4 0C. The mixture 
was washed with the EDTA buffer to remove excess urease and fluorescein-5-thiosemicarbazide.  
The particles were then dried and stored in a glass vial coated with aluminum foil at 4 0C until 
used. 
 
4.2.8 pH Reversibility of the Urea Sensor  
The pH reversibility of the lipobead-based urea biosensors was measured by monitoring 
the change in fluorescence intensity when weak acids or bases were added to a solution of 
fluorescence sensing lipobeads.  The fluorescence intensity was measured as a function of time 
using an excitation wavelength of 490 nm and an emission wavelength of 520 nm.  To conduct 
the measurement, 2 mL of lipobead solution was placed in a 3 mL quartz cuvette (1 cm 
pathlength).  The sample was placed in the fluorimeter cuvette holder and its emission was 
monitored until obtaining a stable baseline. Then, different amounts of weak acid or base 
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solution were injected into the cuvette while the lipobeads solution was stirred.  The emission 
measurement was continuously recorded until a stable baseline was observed.   
FTIR Spectroscopy - Fourier transform infrared (FTIR) spectra of lipobeads solutions at 
25 0C were collected using a Bomem MB-104 FTIR spectrometer equipped with a KBr 
transmission window.  The spectral range was from 700 to 4000 cm-1, with a resolution of 8 cm-1.  
The spectrometer used Win-Bomem software to record the spectra.  32 scans were accumulated 
for each spectrum.  Samples were collected and measured from each synthesis step.   
 
4.2.9 Digital Fluorescence-imaging Microscopy 
The experimental setup used for fluorescence measurements of the lipobeads based 
sensors was reported previously (10). The system consisted of an inverted fluorescence 
microscope (Olympus IX-70) equipped with three detection ports. A 100-W mercury lamp was 
used as the light source for excitation. The fluorescence was collected by a 40 x microscope 
objective. A filter cube containing 460/50 nm excitation filter, 500 nm dichroic mirror, and 515 
nm longpass emission filter was used to ensure spectral purity. A high-performance ICCD 
camera (Roper Scientific, model 256HB) with a 512 x 512 pixel array was used for digital 
fluorescence imaging of the samples.  The software image Pro+ (Media Cybernetics Inc.) was 
used for image analysis.  The exposure time used in most experiments was 0.1 seconds. 
 
4.3 RESULTS AND DISCUSSION 
4.3.1 Synthesis of Lipobead-based Urea Biosensors 
Carboxyl-modified silica microspheres were used as the supportive matrix of the urea 
biosensors.  The abundance of carboxyl groups enabled the covalent binding of phosphatidyl 
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ethanolamine to the particles through a condensation reaction between the amino groups of the 
phospholipid molecules and the activated carboxyl groups on the silica particles to form stable 
amide bonds.  Scheme 4.1 describes the first steps of the urea biosensor synthesis.  The carboxyl 
groups on the silica particles surface were first activated with N-hydroxysuccinimide to facilitate 
the formation of amide bonds when the particles were mixed with amino functionalized 
phospholipids.  The second step of the synthesis involved the acylation of the sn-2 hydroxyl 
groups of the immobilized phosphatidyl ethanolamine with sebacoyl chloride.  This placed a 
terminal carboxylic acid chloride group at the sn-2 position of the immobilized phospholipids.  
The lipobeads were then treated with sodium bicarbonate to convert the terminal acid chloride to 
an acidic moiety in order to enable the covalent conjugation of enzyme and fluorescent 
molecules to the lipobeads.  The carboxylic acid groups were activated with N-
hydroxysuccinimide. Then, a solution containing the enzyme urease and fluorescein-5-
thiosemicarbazide was added to the reaction mixture.  The enzyme and fluorescent molecules 
were attached covalently to the sn-2 acyl chain carboxyl moieties through their free amino 
groups.  The ratio between the enzyme and fluorescent molecules was optimized to realize 
maximum enzyme activity and maximum fluorescence response to urea.  First, we optimized the 
concentration of urease in the lipobead preparation solution.  The activity of the lipobeads 
increased with increasing enzyme concentration up to a level of 4.0 U/mL.  Increasing the 
concentration above this level decreased the enzymatic activity of the lipobeads, which could be 
attributed to steric interactions due to excess of enzyme molecules in the lipobeads membrane.  
To determine the efficiency of the covalent attachment of urease to the phospholipid membrane 
of the sensing particles we monitored the residual fluorescence of the lipobead preparation  
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Scheme 4.1 – Synthesis of activated lipobeads. 
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solution following precipitation of the enzyme-bound lipobeads by slow speed centrifugation.  
Urease molecules fluoresce at 360 nm when excited at 290 nm due to the presence of the 
aromatic amino acid tryptophan in the protein sequence (32).  Figure 4.3 describes the 
fluorescence intensity of free urease as a function of urease concentrations ranging from 1 to 
0.08 mg/mL.  The percentage immobilization curve exhibits considerable non-linearity the insert 
shows linear response in urease concentrations ranging from 1 to 0.02 mg/mL with a correlation 
coefficient of 0.990.  In the immobilization experiments we used lipobeads concentration of 1.6 
mg/mL.  Based on the fluorescence intensity of the supernatant prior to and following enzyme 
immobilization we found that for a reaction mixture containing 0.09 mg/mL urease the residual 
urease concentration in the solution was 0.02 mg/mL indicating that about 80% of urease 
molecules were immobilized to the lipobeads under these conditions. The concentration of 
fluorescein-5-thiosemicarbazide in the lipobeads preparation solution was optimized as well.  
The fluorescence intensity of the lipobeads increased with increasing dye concentration up to a 
level of 0.75 mM.  Increasing the dye concentration above this level resulted in a decrease of the 
fluorescence intensity and pH sensitivity of the lipobeads, which could be attributed to self 
fluorescence quenching of the fluorescein moieties when excessively immobilized to the 
membrane. In our experiments, we used a dye concentration of 0.45 mM in the lipobeads 
preparation solution. This dye concentration resulted in sufficiently bright lipobeads with signal 
to background ratio of ∼50. This was done to maximize the number of binding sites on the 
membrane for the conjugation of urease to the lipobeads. It should be noted that washing the 
lipobeads to remove excess dye was technically difficult since fluorescein-5-thiosemicarbazide  
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Figure 4.3 – A calibration curve of free urease fluorescence versus urease concentrations 
ranging from 0 to 0.1 mg/mL. The shape of the large concentration spanning curve is nonlinear. 
Insert - linear plot of urease fluorescence against. urease concentrations ranging from 0 to 0.02 
mg/mL.  
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has limited solubility in aqueous solution.  The lipobeads were washed repeatedly until their 
fluorescence intensity remained constant. This indicated that only covalently attached 
fluorophores remained in the lipobeads membrane.  
 
4.3.2 FTIR Monitoring of Biosensor Synthesis Steps  
Steps in the synthesis of the lipobead biosensors were monitored using FTIR spectroscopy. 
Figure 4.4a shows an FTIR spectrum of commercially available silica beads dispersed in 
chloroform. Two characteristic absorbance bands at 1640 cm-1 for the carboxylic groups and at 
1105 cm-1 for the Si-O stretch of the silica beads can be seen.  Figure 4.4b shows an FTIR 
spectrum of silica lipobeads dispersed in toluene.  The spectrum contains absorbance bands 
indicative of phospholipids.  New bands are observed in the spectrum at 1227 cm-1 for the 
phosphate groups, at 1468 cm-1 for secondary amines, and at 1731 cm-1 for the palmityl fatty 
ester group of the phospholipids.  Finally, Figure 4.4c shows the spectrum of the lipobeads 
collected after the acylation of the sn-2 hydroxyl groups of the immobilized phosphatidyl 
ethanolamine with sebacoyl chloride, and subsequent acid chloride conversion to the terminal 
carboxylic acid with sodium bicarbonate.  The lipobeads were dispersed in chloroform.  The 
spectrum shows absorbance bands at 1086 cm-1 for the silica groups, at 1220 cm-1 for the 
phosphate group, and a weak band at 1731 cm-1 for the ester group.  As expected, the spectrum 
shows a decrease in the intensity of the ester band at 1731 cm-1 and an increase in the intensity of 
the weak acid band at 1648 cm-1.  A new absorbance band at 1563 cm-1 for the carboxylate ion 
also confirmed the successful completion of this synthesis step.   
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Figure 4.4 – FTIR spectra monitoring different steps of the lipobeads synthesis: (a) bare silica 
beads, (b) silica lipobeads prior to acylation, and (c) silica lipobeads following acylation with 
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sebacoyl chloride. 
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4.3.3 Scanning Electron Microscopy (SEM) and Digital Fluorescent Images of the 
Lipobeads  
An SEM image of the silica beads is shown in Figure 4.5a.  The mono-dispersed particles 
appear spherical in shape with an average diameter of 1.7 µM ± 3%. Figure 4.5b shows an SEM 
image of lipobeads containing urease and flurescein-5-thiosemicarbazide.   There are no 
significant differences between the SEM images of the bare silica particles and the lipobeads as 
the resolution of SEM is not sufficient to observe the phospholipid layer.  However, the mono-
dispersity and shape of the lipobeads indicate that coating the silica particles with a phospholipid 
membrane did not affect the size and shape of the particles, and more importantly did not induce 
particle aggregation. Figure 4.5c shows a digital fluorescence image of lipobeads.  The lipobeads 
appear bright with a signal to background ratio of 50 ± 15%.  The intensity variations between 
lipobeads are attributed to heterogeneity in the excitation light intensity in the microscope field 
of view and to variations in the membrane coating of the lipobeads. 
 
4.3.4 pH Sensitivity and Reversibility of the Lipobeads  
Fluorescein-5-thiosemicarbazide is a pH sensitive fluorescent indicator.  Studies were 
performed to determine whether the immobilization of fluorescein-5-thiosemicarbazide to the 
membrane of the lipobeads affected the pH sensitivity of the fluorescent indicator.  Figures 4.6a 
and 4.6b depict the pH dependent emission spectra of free and immobilized fluorescein-5-
thiosemicarbazide in aqueous solutions buffered with 0.2 mM EDTA at pH 6.0 and 8.0 
respectively.  The spectra were measured at a fixed excitation wavelength of 490 nm and the 
fluorescence intensity was measured at 520 nm. The fluorescence intensity of both free dye and  
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Figure 4.5 – Scanning electron microscopy (SEM) image of (a) bare silica beads, (b) Silica 
lipobeads. Both images reveal that the particles are spherical, evenly dispersed, and average 1.7 
± 3% µM in diameter with narrow size distribution. (c) A digital fluorescence image of the 
lipobeads. The signal to noise ratio is about 50 ± 15%. 
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dye-containing lipobeads solutions increased by about 2-fold when the pH increased from 6.0 to 
8.0.  This indicated that the covalent immobilization of fluorescein-5-thiosemicarbazide to the 
lipobead membrane did not significantly alter its pH sensitivity. Figure 7 describes the pH 
reversibility of the lipobeads. First, the pH was increased from 6.0 to 6.8 by adding drops of 
diluted sodium hydroxide. As expected, an increase in fluorescence intensity was observed. The 
pH was further increased from 6.8 to 7.9. Again, a fluorescence intensity increase was recorded. 
The solution was adjusted back to pH 6.8 and then to pH 6.0 by adding drops of diluted 
hydrochloride acid. Each step brought the fluorescence intensity back to the original value. This 
clearly demonstrated the pH reversibility of the fluorescent sensing lipobeads. 
  
4.3.5 Catalytic Properties of the Urease Lipobead Biosensor 
Using the well-known classical enzyme kinetics model of the Michaelis-Menten (33, 34), 
the Michaelis-Menten constant Km was calculated for the free enzyme, and for the sensing 
lipobeads.  Digital fluorescence images and spectra of the particles were taken at different time 
intervals when the urea sensing lipobeads were exposed to solutions of increasing urea 
concentrations.  Figure 4.8 is a Lineweaver-Burke plot describing the invert of the initial reaction 
rate versus the invert of substrate concentration between 0 and 4 mM. Km of the sensing 
lipobeads was calculated as 7.0 ± 1.8 mM. For free urease, Km was calculated as 1.9 ± 0.04 mM.  
This is in agreement with the literature Km values that range between 1 and 8 mM for free urease 
in solution (35).  It should be noted that the error in the Km determination of the lipobeads is 
significantly higher than the error in the determination of Km in free urease solutions.  This is 
attributed to the small number of lipobeads, about 50, in the images and spectra used to 
determine the rate of the enzymatic reaction.  Increasing the lipobead concentration would make  
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Figure 4.6 –The pH dependent emission spectra of (a) 0.05 mM fluorescein-5-thiosemicarbazide 
in 0.2 mM EDTA solution and (b) lipobeads solution containing fluorescein-5-thiosemicarbazide 
between pH 6.0 and 8.0 in a 0.2 mM EDTA solution. The spectra were measured at a fixed 
excitation wavelength of 490 nm and the fluorescence intensity was measured at 520 nm.  
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Figure 4.7 – pH reversibility study describing the fluorescence intensity of the urea sensing 
lipobeads versus time at different pH levels.  
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it difficult to discriminate between the responses of individual particles.  On the other hand, 
spectro-fluorimetry measurements of urea sensing lipobeads in solution did not significantly 
reduce the error in the Km analysis due to added scattering noise.  It is fair to conclude that the 
variability in membranal coating and enzyme immobilization remained the performance limiting 
parameters of the lipobead-based biosensors.  Another interesting observation was the relatively 
large Km of the urea sensing lipobeads compared to the Km of urease in solution.  In enzyme 
kinetics, Km is a measure of the enzyme-substrate binding affinity where a large Km indicates 
low binding affinity since a high substrate concentration ([S]) is required to reach Vmax/2.  On the 
other hand, a small Km indicates higher binding affinity since a lower [S] is required to reach 
Vmax/2.  The higher Km value of 7.0 ± 1.8 mM for the lipobeads compared to 1.9 ± 0.04 mM for 
free urease indicates that the reaction rate decreased for the urea sensing lipobeads. This is also 
reflected in the two orders of magnitude lower Vmax of the lipobeads compared to that of free 
urease. The increase in Km and decrease in Vmax are attributed to the additional diffusion barrier, 
which must be overcome by the urea molecules when permeating through the phospholipid 
membrane. Figure 4.9 shows a semi-log calibration curve of the response of the lipobead-based 
urea biosensors to increasing concentrations of urea. Each data point was the average of three 
replicate measurements. The error bars were calculated based on the standard deviation of the 
three replicate measurements. The dynamic range of the urea sensing lipobead was between 0.1 
and 4 mM which is comparable with previously developed large fluorescence-based urea 
biosensor (22). With the proper dilutions, the urea sensing lipobeads should be applicable to the 
measurement of urea in both serum and urine. The urease activity is the only performance of 
limiting parameter by the newly developed lipobead-based urea biosensors. The covalent  
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Figure 4.8 – A Lineweaver-Burk plot of the invert of the initial reaction rate versus invert 
substrate concentration. Km was calculated at 7.0 ± 1.8 mM for the urea sensing lipobeads. 
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coupling of the fluorescent indicator and urease to the lipobeads eliminated stability problems 
related to dye and enzyme leakage from the lipobead membrane. After two months in storage 
only 10% loss in activity was observed demonstrating the extended stability of the urea sensing 
lipobeads. 
 
4.4 CONCLUSIONS 
  This paper describes an improved synthesis protocol for the fabrication of fluorescence 
biosensing lipobeads. Silica particles modified with carboxyl groups were used to prepare the 
lipobeads. They were coated with functionalized phospholipids to form the membrane coated 
beads. The enzyme urease and the pH sensitive indicator fluorecein-5-thiosemicarbazide were 
attached covalently to the lipobeads membrane. SEM and digital fluorescent images showed that 
the synthesized lipobeads were bright and evenly dispersed, and no apparent aggregation was 
observed.  This work represents a departure from the previous use of polystyrene particles as a 
supporting matrix for fluorescence sensing lipobeads.  Polystyrene particles of different surface 
functionalities (NH2, COOH, SH) are available commercially.  Furthermore, there is large body 
of work in the literature that describes the conjugation of fluorophores and biomolecules to 
polystyrene particles.  However, our recent studies indicated that size reduction of polystyrene 
particles to submicrometric dimensions often led to their aggregation.  Additionally, polystyrene 
particles undergo shape deformations in different solvents and ionic strength, which decrease 
their leaking stability.  Polystyrene particles were also shown to be quite toxic.  On the other 
hand, silica particles have been recently used as drug carriers without noticeable side effects.  
This paper describes the use for the first time of submicromteric silica particles as the core of  
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Figure 4.9 – A semi-log plot describing the fluorescence intensity of the urea sensing lipobeads 
against increasing urea concentrations.   
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urea sensing lipobeads.  Tests performed to determine the effect that immobilization of the 
fluorescent indicator to the lipobeads had on the pH sensitivity of the fluorescent indicator 
demonstrated that the response of the immobilized pH indicator did not change appreciably due 
to immobilization. The working range of the immobilized fluorescein-5-thiosemicarbazide 
indicator was between pH 6 and 8.5. Reversibility studies indicated that the lipobeads responded 
to pH increase or decrease with high reproducibility. The dynamic range of the lipobeads-based 
urea biosensors was determined to be from 0.1 mM to 4 mM. Through the use of Lineweaver-
Burke plots, the Michaelis-Menten constant Km for the lipobeads particles was calculated to be 
7.0 ± 1.8 mM, 3.7 fold higher than the Km of free urease. This indicated that immobilization of 
urease to the membrane of the lipobeads decreased the rate of the hydrolase conversion of urea 
into ammonia. This was expected due to the membrane addition of a diffusion barrier in the 
lipobeads. However, the dynamic range and sensitivity of the lipobeads are still sufficient to 
measure normal and elevated urea concentrations in diluted biological fluids. In addition to 
increased stability compared to previously reported particle-based sensors, the lipobead-based 
biosensors could prove useful in in-vivo experiments where preventing particle endocytosis 
would be essential for long term monitoring of urea in serum. The phospholipid coating of the 
particles was previously shown to be effective in lowering endocytotic rate. Future studies will 
focus on the application of fluorescent biosensing lipobeads in in-vitro and in-vivo 
measurements. 
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CHAPTER V  DELIVERY OF PARTICLES INTO CELLS FOR 
INTRACELLULAR MEASUREMENTS 
 
5.1 Introduction 
Loading nanosensors and macromolecules into cells, by transfection or translocation 
through the cellular membrane, to probe biological systems is an evolving area of research for 
probe sensing and drug delivery.  Numerous methods exist for loading fluorescence labeled 
sensing particles into cells such as mechanical loading, chemical reagent loading, and 
electroporation (1). Mechanical loading includes direct microinjection methods (2) or “gene gun” 
methods (3) which can be used to load indicators to specific area in cells. Mechanical loading 
methods require harsh conditions which often lead to either cell injury, cell death, or both.  
Scrape loading, which has been demonstrated to load large nanoparticles of similar dimensions 
to nanoparticles into the cytoplasm of cells (4), was also observed to be a fatal method when 
applied to fibroblasts. Mild agitation was the alternative method used which demonstrated that 
scrape loading is not amicable to all cell types. Receptor-mediated endocytosis has also been 
reported for intracellular nanoparticle delivery, however, it is not effective for particles greater 
than 100 nm (5,6).  Mild sonication has also been reported for large macromolecules os similar 
dimensions to nanoparticles delivery into cells, but is primarily limited to loading cells that are in 
a suspension (7). Cationic transfection reagents such as TransIT®-293, GenePORTERTM, and 
GeneJuice® have also been successfully used for intracellular nanoparticle delivery (8-10). This 
method can deliver submicron-sized particles with efficiency of ~11% (11). In a typical 
experiment, certain amounts of submicron particles in serum free medium is mixed with the 
transfection agent, incubated in serum free medium for 4 hrs, washed with complete growth 
medium, and then incubated with complete growth medium for another 24 hrs. However, for this 
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method to work the submicron particle surface must have negative charges. If the particle surface 
has no negative charges, it will lead to poor loading efficiency (2). Another associated charge 
problem can arise when polyanion species are present, such as heparin or dextran sulphate, as 
contaminants, which are known to inhibit the transfection efficiency. Also reported has been the 
difficulty of removing particles that were adhered  to the cell surface without damaging the cells 
(12). 
Recently, an alternative approach for cellular uptake of nanoparticles has been developed, 
which involves the use of cell-penetrating peptides (CPPs) (13). CPPs such as the Tat peptide, 
polyarginine, and penetratin have membrane translocating properties which allow them to enter 
into cell (14). The mechanism by which the CPPs are internalized into cells has been ascribed to 
both endocytosis and to free energy passage directly through the lipid bilayer of the cell 
membrane. However, it is the second mechanism of a direct transport through the lipid bilayer of 
cell membrane that has been the most widely accepted mechanism for internalization of CPP’s. 
Recently, Richard et al. (13), reevaluated the uptake mechanism for the CPP’s Tat 48-60 and 
(Arg)9. Their findings showed that past measurement methods based on fluorescence-activated 
cell sorting (FACS) analysis and fluorescence microscopy on fixed cells required adjustments for 
proper determination of CPP internalization. Following adjustments to the methodologies, they 
reported the observance of a direct role of endocytosis for cationic CPP internalization. CPPs are 
derived from the “protein-transduction domains” of proteins like HIV-1 Tat, HSV-1 VP22, and 
Drosophilia Antennapedia homeoprotein (15). The active peptide domains of CPPs contain as 
major residues the basic amino acid  arginine and lysine (16). At physiological pH CPP’s are 
highly cationic (17), and often have a conformation that is alpha helical (18).  Intracellular 
studies using CPPs include: tracking the differentiation and distribution of stem and progenitor 
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cells (19), the transportation into cells of heterologous proteins (20), gene delivery systems 
which are nonviral (21), and delivery of antibody fragments for tumor-targeting (22,23). 
Recent work to internalize nanoparticles using the Tat cell penetrating peptide has been 
reported using magnetic nanoparticles for in vivo tracking and recovery of progenitor cells (24), 
for hepatic permeability studies in rats (25), for cellular uptake studies in mice spleen 
lymphocytes (26), and uptake studies in HeLa cells (27). The magnetic nanoparticles were iron 
oxide crystals comprised of ~2000 iron atoms, and averaged less than 10 nm in diameter. The 
Tat peptide has also been coupled to liposomes to study the internalization of liposomes into 
cancer cells (28). The liposomes were used as drug or DNA delivery vesicles. They have 
averaged in diameter 200 nm. Liposomes, however, are not rigid body particles and may be able 
to deform their shape during the internalization process. Quantum dots, which have diameters 
smaller than 10 nm, were also coupled to the amphipathic peptide Pep1 to facilitate their cellular 
internalization (2). The objective of our studies was to determine whether CPPs could facilitate 
the permeation of larger particles into single cells. 
 
5.2  EXPERIMENTAL 
5.2.1 Digital Fluorescence-imaging Microscopy 
The experimental setup used for fluorescence measurements of the nanoparticles based 
sensors was reported previously (29). The system consisted of an inverted fluorescence 
microscope (Olympus IX-70) equipped with three detection ports. A 100-W mercury lamp was 
used as the light source for excitation. The fluorescence was collected by a 40 x microscope 
objective. A filter cube containing 470-490 nm excitation filter, 505 nm dichroic mirror, and 515 
nm longpass emission filter was used to ensure spectral purity. A high-performance ICCD 
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camera (Roper Scientific, model 256HB) with a 512 x 512 pixel array was used for digital 
fluorescence imaging of the samples.  The software image Pro+ (Media Cybernetics Inc.) was 
used for image analysis.  The exposure time used in most experiments was 0.1 seconds. 
 
5.2.2 Synthesis of Tat Peptide and Flubida Coated Nanoparticles 
Streptavidin-beads will absorb onto Eppendorf tubes very easily so the tubes are coated 
with a 10 mg/mL bovine serum albumin (BSA) solution to avoid the nonspecific absorption. The 
BSA is dissolved in Dulbecco’s PBS buffer and added to the disposable tubes to make a final 
concentration of 10 mg/mL. The BSA solution is incubated overnight in the tube and then rinsed 
with PBS buffer to prepare for the next step. The streptavidin is also coated with BSA to inhibit 
non-specific absorption onto the beads surface. 6 µL beads suspension is mixed with 1 mL 
Dulbecco’s PBS buffer, mixed well, then 10 µL of a 100 mg/mL BSA dissolved in PBS solution 
is added to the mixture and incubated for 20 min. The beads are then washed 3 times by 
centrifuge at a speed of 14000 rpm for 15 min. The longer reaction time may reduce the beads 
binding capacity for biotin because it is possible that BSA eventually becomes absorbed onto the 
beads surface and block the specific biotin binding. The supernatant is then dispersed in 200 µL 
PBS buffer and mixed with 8 µL 200 µM flubida-biotin and 8 µL 200 µM biotin for control 
experiments, or the beads solution mixed with 8 µL flubida-biotin and 8 µL 200 µM Tat peptide 
solution, overnight. The beads are then washed three times with PBS buffer. To avoid 
photobleaching of the dye, the processed beads in their final vial are always covered by 
aluminum foil and stored in a refrigerator at 4 oC until used.  
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5.2.3 Permeation of Nanoparticles into Cells 
We have tested the Tat peptide mediated uptake of nanoparticles by using two different 
cell lines, MCF 7 and Hela cancer cells under varying incubation times. All of the experiments 
were performed at 37 0C under a 5% CO2 atmosphere. After initial growth in tissue culture 
flasks, the cells were collected and diluted into 1×106 cells/mL cell growth medium. Standard 
hemacytometry was used to determine the cells concentration and viability with trypan blue 
staining (30,31). The cells were planted and incubated in coverslip covered chamber wells for 
80% confluency. The cells were washed with serum free medium, or Dulbecco’s PBS buffer, 
then mixed with nanoparticles in a sterilized hood environment and incubated at varied times. 
After incubation, the cells were washed with PBS buffer (pH 7.2) to remove extra nanoparticles 
and analyzed by digital fluorescence microscopy, spectrofluorimeter, and microplate reader.   
 
5.3 Results and Discussion 
5.3.1 Choice of Fluorescence Indicator 
The probe chosen for fluorescent labeling of the sensor under development was flubida-2, 
which is a conjugate between fluorescein diacetate and biotin. This fluorophore is non-
fluorescent before penetrating into cells under physiological pH conditions. Figure 1 illustrates 
the structure of flubida-2 (32). The advantage of this indicator is that there is no background 
fluorescence from extra flubida-2 being present during intracellular measurements because it is 
non-fluorescent under physiological pH conditions. The mechanism responsible for activation of 
the flubida-2 fluorescence is controlled by enzymatic activity where after the flubida-2 has 
penetrated into the cells, the esterase enzyme will catalyze the diacetate to acid, changing the 
fluorescein diacetate to fluorescein, which then emits fluorescence. The mechanism for the 
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conversion of flubida-2 to fluorescein is shown below. In the developed sensor the flubida-2 is 
covalently bound to the avidin microspheres. With the aide of the Tat peptide, which acts as a 
cell penetrating peptide, the microspheres will penetrate into the cells and emit fluorescence. 
Thus allowing the sensing and subsequent measurement of the pH in the cytoplasm.  
To determine whether the modification of flubida-2 would have an affect on its pH 
dependant fluorescence properties, we scanned the emission spectra of free flubida-2 and 
flubida-2 modified polystyrene particles in a physiological pH 7.4 solution and in a pH 10 basic 
solution. The flubida-2 concentration used in the tests was 2 ųM. Figure 5.2(a) illustrates that the 
free flubida fluorescence intensity was observed to increase after changing the pH from 7.4 to 
10. After modifying flubida-2 onto the polystyrene particles, the fluorescence intensity still 
increased with increasing pH, as illustrated in Fig. 5.2(b), demonstrating that the pH dependant 
fluorescence properties had not changed. 
5.3.2 Coupling of Tat Peptide and Flubida to Nanoparticles 
Although the avidin-biotin binding is known to be a very strong noncovalent binding, 
streptavidin was used in the development of the bead sensor instead of avidin. Streptavidin 
shows less nonspecific binding to the particles compared to avidin. Streptavidin is very similar to 
avidin in structure. It has four subunits, each can bind to a single biotin molecule. Both 
streptavidin and avidin are resilient proteins that can tolerate a variety of buffer conditions, 
different pH values, and many chemical modifications. To optimize the amount of flubida biotin 
and Tat peptide conjugated to the particles, control experiments were performed in which flubida 
biotin was replaced with the fluorescent dye 5-((N-(5-(N-(6-(biotinoyl) amino)   
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Figure 5.1. Flubida structure and esterase conversion to the fluorescent species (32). 
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hexanoyl)amino)pentyl)thioureidyl)fluorescein (fluorescein biotin), and the Tat peptide was 
replaced with biotin (multiple control experiments using the Tat peptide are prohibitive due to 
high cost). The fluorescence intensity of fluorescein biotin was quenched when the dye was 
bound to the streptavidin coated nanoparticles. The fluorescence quenching could be attributed to 
the formation of nonfluorescent aggregates on the particle surface due to interaction of the 
fluorescein molecules with unsaturated steptaviding binding sites (33). To overcome this 
problem, 200 µM biotin was added to the fluorescein biotin and beads solution. This minimized 
the fluorescence due to the decreasing availability of streptavidin binging sites  
 
5.3.3 Microscopy Studies of Nanoparticls Permeation into Cells 
The particle-based sensors in our experiments averaged 120 µm in diameter. To 
determine whether these particles can penetrate into MCF7 cells, the particles were incubated 
with the cells, in a controlled environment incubator, for 4 hours at 37 0C under a 5% CO2 
atmosphere.  The samples were then removed from the incubator and washed with Dulbecco’s 
PBS buffer three times. The chambered coverglasses containing the cells and particles were then 
monitored by digital fluorescence microscopy. If the particles have penetrated into the cells, only 
the cells should fluoresce. There should be minimal background fluorescence from particles 
outside of the cells since flubida-2 is non-fluorescent under physiological conditions. Figure 5.3 
illustrates the digital images of nanoparticles incubated with MCF 7 cells where (a) is the MCF 7 
cells transmission image, and (b) is the digital fluorescence image of MCF 7 cells and particles.  
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Figure 5.2. (a) 2 uM flubida-biotin at pH7.4 and pH10.0. (b) 6 uL 120 nm streptavidin 
microspheres at pH7.4 and pH10.0.  
 
 91 
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Figure 5.3. Digital images of particles with MCF 7 cells where (a) is the MCF 7 cells 
transmission image, and (b) is the digital fluorescence image of MCF 7 cells and particles. 
 
 
 92 
 
 (a) 
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(c) 
 
Figure 5.4 Digital images used to determine whether the particles are penetrating into the Hela 
cells. (a) Hela cells transmission image, (b) overlap of the transmission-fluorescence image of 
the Hela cells, and (c) digital fluorescence image. 
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The images do not readily demonstrate whether the particles have penetrated into the 
cells or not.  But Figs 5.3 (a) showed 70-80% cells confluency and MCF 7 cells were alive which 
was confirmed with trypan blue.  Figs 5.3 (b) demonstrated that some cells fluoresce indicating 
nanoparticles internalization or attachment of flubida into the cells. To determine if penetration 
has taken place, experiments were performed that attempted to compare MCF 7 and Hela cells 
for particle penetration confirmation. The first experiment involved incubating the particles with 
Hela cells under the same condition as was performed for the MCF 7 cells. Generally, Hela cells 
are known to more easily engulf an intruder such as the sensors than the MCF 7 cells. Figure 5.4 
shows the digital images of the experiment to determine whether the particles are penetrating 
into the Hela cells. In Figure 5.4, (a) is the Hela cells transmission image, (b) is an overlap of the 
transmission-fluorescence image of the Hela cells, and (c) is the digital fluorescence image. Figs 
5.4 (a) demonstrated the Hela cells were smaller than MCF7 cells and Hela cells had 40-50% 
confluency, Figs 5.4 (b), (c) illustrated that less labling were showed in Hela cells than in MCF 7 
cells, However, the images still did not demonstrate that the particles have penetrated inside the 
cells. 
 
5.3.4  Proving That the Microscopy Results are an Artifact 
From the digital microscopy images shown above for the penetration experiments, it 
could not be determined whether the particles had penetrated inside the cells. Under the above 
described experiment of incubating the particles in a suspension of cells for 4 hours at 37 0C 
under 5% CO2 atmosphere and measuring the fluorescence by fluorimeter, the comparison of the 
fluorescence intensity before and after the particles were incubated with cells was done. 
However, the fluorescence intensity change was too small to prove that the particles were inside 
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the cells. To illustrate this, Figure 5.5 shows a plot of the emission spectra comparing the 
particles in a suspension of Hela cells where (a) is the mixture of particles with the Hela cells 
representing a baseline measurement of the fluorescent emission, (b) is the fluorescent emission 
after 4 hours of incubation, and finally (c) is the fluorescent emission after adjusting the pH to 10 
with KOH. As can be seen in the graph, after incubating the nanoparticles with the cells for four 
hours, only a small increase in fluorescence intensity was observed. The slight fluorescence 
intensity increase that was observed may due to cellular auto fluorescence. Therefore, if the 
particles did not get inside the cells, they must still be in the solution. After measuring the 
fluorescence intensity of the incubated particles with cells, we added drops of concentrated 
potassium hydroxide to adjust the pH from 7.4 to 10.0. Upon adjusting the pH, the fluorescence 
intensity increased significantly, which suggested that the nanoparticles did not efficiently 
penetrate into the cells. The same experiment was performed using the MCF 7 cells. The results 
were very similar to the ones with Hela cells, but after 4 hours incubation, the fluorescence 
increase was even smaller than was what observed with Hela cells.  Hela cells were used for the 
rest of the experiments because Hela cells are generally exhibiting higher permeability. 
The next step taken was to use a microplate reader to quantitate the penetrating efficiency 
of the sensors into the cells. The microplate reader is very similar to a fluorometer. However, this 
is the only system that can provide dual-mode measurement for a cuvette port and a 6-384 
microplate reading setup. In the microplate reader setup for a 96 well microplate reading, the 
conditions to incubate the particles with cells were the  
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Figure 5.5. Plot of the emission spectra comparing the particles in a suspension of Hela cells 
where (a) is the mixture of particles with the Hela cells representing a baseline measurement of 
the fluorescent emission, (b) is the fluorescent emission after 4 hours of incubation with cells, 
and (c) is the fluorescent emission after adjusting the pH to 10 with KOH. 
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same as the ones used for the incubation experiments measured by digital fluorescence 
microscopy reported above.  The incubation experiments included cells with cell growth 
medium, free fluibda, particles covalently bound with flubida, and particles covalently bound 
with either flubida or the Tat peptide separately. Figure 5.6 shows the microplate reader results 
with cells treated with (a) 20 µL Dulbecco’s buffer, (b) 20 µL Tat peptide, (c) 20 µL particles 
with cells, (d) 20 µl flubida covalently bound particles incubated with 
the cells for four hours, and (e) flubida and Tat peptide covalently bound particles incubated with 
the cells for 4 hours.  
In Figure 5.6(a), only an initial increase in fluorescence intensity was observed with the 
buffer additive indicating cellular autofluorescence. The fluorescence intensity in Fig. 5.6(b) is 
also probably due to cellular autofluorescence. The fluorescence reading for Fig. 5.6(c) was very 
similar to (b), which means that the Tat peptide and particles were not fluorescent.  In Fig. 5.6(d) 
there was observed a two-fold increase in the fluorescence intensity for the flubida covalently 
bound particles incubated with the cells. In Fig. 5.6(e) the fluorescence intensity increased less 
than two-fold. This result was not expected because it was assumed that the Tat peptide would 
facilitate particle penetration into the cells.  
The next experiment was performed to determine whether the problem was from the cell 
medium.  Using the microplate reader, the fluorescence intensity was measured for free flubida 
in (a) blank well, (b) 20 uL cell medium, (c) 20 µL Dulbecco’s buffer, (d) 20 uL serum free 
medium, (e) 20 uL flubida biotin in cell growth medium, (f) 20 uL flubida biotin in Dulbecco’s 
buffer, and (g) 20 uL flubida biotin in serum free medium. Figure 5.7 shows the graphical results 
of the timed fluorescence intensity studies for free flubida in Dulbecco’s PBS buffer, cell growth 
medium and serum-free medium. Both Fig.s 5.7(a) and (c) show very low levels of fluorescence 
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which means the measured signal is primarily from background fluorescence. Fig.s 5.7(b) and 
(d) illustrate that the cell growth medium was emitting fluorescence due to the aromatic amino 
acid composition of the medium. Fig. 5.7(e) demonstrates that the flubida biotin complex was 
converted to the fluorescein biotin complex when in cell growth medium with increasing 
incubation time. Fig. 5.7(f) illustrates that the flubida biotin complex was not affected by 
Dulbecco’s buffer. Fig. 5.7(g) demonstrates that less of the flubida biotin complex was converted 
to the fluorescein biotin complex in the serum free medium than what was observed to be 
converted in the cell growth medium. From the graphs, it can be concluded that the flubida biotin 
complex fluoresces in cell media including both the cell growth medium and the serum free 
medium. However, in serum free medium, the flubida biotin complex emits less fluorescence 
than that in the cell growth medium. Finally, it was observed that flubida does not convert to 
fluorescein in Dulbecco’s PBS buffer.  
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Figure 5.6. Microplate reader results for cells treated with (a) 30 µL Dulbecco’s buffer, (b) 30 
µL Tat peptide, (c) 30 µL particles with cells, (d) 20 µL flubida covalently bound particles 
incubated with the cells for four hours, and (e) flubida and Tat peptide covalently bound particles 
incubated with the cells for 4 hours.  
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Figure 5.7. Fluorescence intensity versus time for free flubida in (a) blank well, (b) 30 uL cell 
medium, (c) 30 µL Dulbecco’s buffer, (d) 30 uL serum free medium, (e) 20 uL flubida biotin in 
cell growth medium, (f) 20 uL flubida biotin in Dulbecco’s buffer, and (g) 20 uL flubida biotin 
in serum free medium. 
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A 24-hour cell viability study of incubating the cells in cell growth medium, serum free 
medium, serum free medium (PBS, v/v, 1/1), and Dulbecco’s PBS buffer was performed. The 
results of the study are shown in Table 5.1. From the tabulated results it can be seen that the cells 
were alive in all four different media up to six hours. After six hours, the cells incubated in PBS 
buffer started to die. If the particles can penetrate into the cells, they should have penetrated 
within 6 hours. To avoid the use of the different media which may pose an interference problem 
(i.e., GM, SFM, and SFM: PBS) the viability study demonstrates that Dulbecco’s buffer can be 
used as the medium for incubating the particles with the cells.  
 
 
Time (h) Growth 
Medium (%) 
Serum Free 
Medium (%) 
Serum Free 
Medium: PBS 
(v/v, 1/1) (%) 
PBS (%) 
2 99 ± 4.8 98.4 ± 6.8 95 ± 3.8 90.4 ± 5.0 
4 96.3 ±5.0 92.4 ± 5.9 92.5 ± 7.8 88.8 ± 4.6 
6 94.5 ± 3 91.7 ± 7.5 90 ± 8.6  89.3 ± 7.8 
8 85.3 ± 5 90.9 ± 9.1 85.2 ± 4.6 77.2 ± 5.3 
12 89.6 ± 4.6 80.9 ± 9.0 81.4 ± 7.2 73.7 ±  15.0 
24 85.9 ± 8.9 85.8 ± 14.0 78.2 ± 17.0 55.9± 20.0 
 
 
Table 5.1. 24 hour cell viability study. 
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From Fig. 5.7 it was summarized that serum free medium did induce flubida to emit 
fluorescence. But in serum free medium, flubida emitted less fluorescence than that in cell 
growth medium. It is assumed that if the serum free medium was diluted with Dulbecco’s PBS 
buffer, less fluorescence would be emitted from flubida so that the fluorescence could be 
ignored. A comparison was made for particles incubated with cells in serum free medium, in 
Dulbecco’s PBS buffer (v/v, 1/1), and particles incubated in serum free medium-PBS buffer. 
Figure 5.8 shows the comparison of the results. Fig.s 5.8(a) and 5.8(b) represent the background 
signal from control blanks. Figures 5.8(c), (d), (e), and (f) demonstrate that the particles had 
similar increases in fluorescence intensity with and without cells, which appears to prove that the 
serum free cell medium did convert the flubida into fluorescein, and the particles did not 
penetrate inside the cells after the conversion. At the same time, we observed that the Tat peptide 
did not facilitate the penetration of the nanoparticles into the cells. There are two possibilities 
why the Tat peptide did not work. The first possibility is that the Tat peptide was stored too long 
thereby greatly reducing its efficiency; the other possibility is that our experimental design was 
not correct, and needs to be adjusted. Torchilin, V. P. et al. (34) demonstrated that the Tat 
peptide works most efficiently after adding a spacer between the particles and the Tat peptide. 
Based on this idea, we can modify our 120 nm particles with polyethylene glycol (PEG) as a 
spacer, and then the Tat peptide can covalently bind to the PEG terminus-reactive amine group. 
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Figure 5.8. Comparison of nanoparticles incubated with cells in (a) control blank, (b) serum free 
medium- buffer (v/v, 1/1)(SFMB), (c) 20 µL particle-flubida incubated in cell with SFMB, (d) 
20 µL particle-flubida-Tat incubated in cell with SFMB, (e) 20 µL particle-flubida incubated in 
SFMB, (f) 20 µL particle-flubida-Tat incubated in SFMB. 
 
 107 
 
5.4 Conclusions 
We have studied the use of cell penetrating peptides to facilitate the permeation of 
nanoparticles averaging 120 nm in diameter into cells. We have successfully attached the Tat 
peptide and the fluorophore flubida-2 to streptavidin coated particles using streptavidin biotin 
interactions. The immobilization of Tat and flubida did not affect their free solution properties. 
Initial microscopy observations suggested that the particles permeated into cells. It was unclear 
whether the particles were only attached to the membrane or indeed penetrated through the cell 
membrane into the cell cytoplasm. A more detailed study revealed that flubida-2 is unstable in 
cell growth medium and even in serum free medium. It was therefore possible that the acetate 
groups would be cleaved off the fluorescein skeleton of the molecule extracellularly. This led to 
fluorescein intensity increase of the particles without actual permeation into the cells. This 
negative result was also confirmed using averaged fluorescence measurements of cells in a well 
plate reader format. In these experiments the fluorescence enhancement observed when Tat and 
flubida coated particles were incubated with both MCF-7 and Hela cells under various 
incubation conditions was neglible. Future experiments will focus on the use of phosphate buffer 
solutions rather than growth medium as an incubation media. The incubation time will be 
shortened to ensure cell viability. If this step would prove unsuccessful we prove to increase the 
length of the linker that connects between the Tat peptide and the particles. Recent studies 
showed that increasing the linking length increases the penetration efficiency of cargo carried by 
cell penetrating peptides into cells. 
Future studies will also focus on the use of these particles as intracellular pH sensors. 
However, to realize this goal the particles must be first internalized effectively by the cells of 
interest. 
 108 
 
5.5   References 
1. Tai-Kin Wong and Eberhard Neumann, Biochem Biophys Res Commun 1982, 107, 584-
587.  
2. Jaiswall, J.K., Goldman, E.R., Mattoussi, H. & Simon, S.M., Nature Methods, 2004, 1(1), 
1-6. 
3. E.F. Fynan, R.G. Webster, D.H. Fuller, J. R. Haynes, J.C. Santoro and H.L. Robinson, 
Proc. Natl. Acad. Sci. U.S.A., 1993, 90, 11,748-11,782. 
4. McNeil, P.L., Murry, R.F., Lanni, F., and Taylor, D.L., J Cell Biol 1984, 98, 1556. 
5. X.-H. N. Xu, J. Chen, R. B. Jeffers and S. Kyriacou, Nano Lett., 2002, 2, 175–182. 
6. S. Prabha, W.-Z. Zhou, J. Panyam and V. Labhasetwar, Int. J. Pharm., 2002, 244, 105–
115. 
7. Fechheimer, M., Denny, C., Murphy, R.F., Taylor, D.L. Eur J Cell Biol, 1986, 40, 242. 
8. Voura, E.B., Jaiswal, J.K., Mattoussi, H. & Simmon, S.M., Nat. Med. 2004, 10, 993-998. 
9. Kneuer, C., Sameti, M., Bakowsky, U., Schiestel, T., Schirra, H., Schmidt, H. and Lehr, 
C.-M., Bioconjugate Chem., 2000, 11, 926-932. 
10. Sandhu, K.K., McIntosh, C.M., Simard, J.M., Smith, S.W. and Rotello, V.M., 
Bioconjugate Chem, 2002, 13, 3-6. 
11. Zhao, Y., Sadtler, B., Lin, m., Hockerman, G.H. and Wei. A., Chem. Commun. 2004, 
784-785. 
12. Sandhu, K.K., McIntosh, C.M., Simard, J.M., Smith, S.W. and Rotello, V.M., 
Bioconjugate Chem, 2002, 13, 3-6. 
13. Richard, J.P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M.J., 
Chernomordik, L.V., Lebleu, B. J. Biol. Chem. 2003, 278, 585-590. 
14. Wunderbaldinger, P., Josephson, L., Weissleder, R. Bioconjugate Chem. 2002, 13, 264-
268. 
15. Violini, S., Sharma, V., Prior, J.L., Dyszlewski, M., Piwnica-Worms, D. Biochemistry 
2002, 41, 12652-12661. 
16. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., Sugiura, Y. J. Biol. 
Chem. 2001, 276, 5836-5840. 
17. Gammon, S.T., Villalobos, V.M., Prior, J.L., Sharma, V., Piwnica-Worms, D. 
Bioconjugate Chem. 2003, 14, 368-376. 
18. Torchilin, V.P., Rammohan, R., Weissig, V., Levchenko, T.S. Proc. Natl. Acad. Sci. USA 
2001, 98, 8786-8791. 
19. Lewin, M., Carlesso, N., Tung, C.H., Tang, X.W., Cory, D., Scadden, D.T., Weissleder, 
R. Nature Biotech, 2000, 18, 410-414. 
20. Fawell, S., Seery, J., Daike, Y., Moore, C., Chen, L.L., Pepinsky, B., Barsoum, J. Proc. 
Natl. Acad. Sci. USA 1994, 91, 664-668. 
21. Avrameas, A., Ternyck, T., Gasmi, L., Buttin, G. Bioconjugate Chem. 1999, 10, 87-93. 
22. Niesner, U., Halin, C., Lozzi, L., Gunthert, M., Neri, P., Wunderli-Allenspach, H., Zardi, 
L., Neri, D. Bioconjugate Chem. 2002, 13, 729-736. 
23. Zhou, X., Chang, Y.C., Oyama, T., McGuire, M.J., Brown, K.C. J. Am. Chem. Soc. 2004,  
24. Lewin, M., Carlesso, N., Tung, C.H., Tang, X.W., Cory, D., Scadden, D.T., Weissleder, 
R. Nat. Biotechnol. 2000, 18, 410-414. 
25. Wunderbaldinger, P., Josephson, L., Weissleder, R. Bioconjugate Chem. 2002, 13, 264-
268. 
 109 
 
26. Zhao, M., Kircher, M.F., Josephson, L., Weissleder, R. Bioconjugate Chem. 2002, 13, 
840-844. 
27. Koch, A.M., Reynolds, F., Kircher, M.F., Merkle, H.P., Weissleder, R., Josephson, L. 
Bioconjugate Chem. 2003, 14, 1115-1121. 
28. Torchilin, V.P., Rammohan, R., Weissig, V., Levchenko, T.S. Proc. Natl. Acad. Sci. USA 
2001, 98, 8786-8791. 
29.  Lentz, B. R.; Carpenter, T. J.; and Alford, D. R. Biochemistry, 1987, 26, 5389. 
30. Ji, J.; Rosenzweig, N.; Griffin, C.; Rosenzweig, Z. Anal. Chem. 2000, 72(15), 3497-3503. 
31. Ji, J.; Rosenzweig, N.; Jones, I.; Rosenzweig, Z. Anal. Chem., 2001, 73(15), 3521-3527.  
32. Wu, M.M., Llopis, J., Adams, S., McCaffery, J.M., Kulomaa, M.S., Machen, T.E., 
Moore, H.P.H., Tsien, R.Y. Chemistry & Biology, 2000, 7, 197-209. 
33. Buranda, T, Jones, G.J., Nolan, J.P., Keij, J., Lopez, G.P., and Sklar, L.A. J. Phys.Chem. 
B, 1999, 103, 3399-3410. 
34. Torchilin, V.P., Rammohan, R., Weissig, V., Levchenko, T.S. Proc. Natl. Acad. Sci. USA 
2001, 98, 8786-8791. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 110 
 
CHAPTER VI:  SUMMARY AND CONCLUSIONS 
 
Fluorescence techniques are regarded as very sensitive and informative tools for cellular 
analysis. Combining the methods of spectrofluorimetry, digital fluorescence microscopy, and 
microplate reader, we can quantify not only intracellular, but also extracellular analysis in 
cellular environments and in biological fluids. The design of our chemical and biochemical 
sensors are compatible with cellular analysis, much more reproducible than those previously 
developed.  In my dissertation, it includes the development of lipobeads based sensors for 
chloride measurement, urea measurement and intracellular measurement by nanoparticles 
penetrating into cells. 
In our lab, we have developed particle-based sensors called lipobeads that are made of 
polystyrene particles coated with a phospholipids membrane, and the fluorescent indicators are 
embedded inside or outside the phospholipids membrane. This type of sensor is biocompatible 
with intracellular and extracellular analysis, and has a relatively fast response time while 
displaying high sensitivity. However, we have always had problems with reducing the lipobeads 
sizes and minimizing the sensor aggregation to as little as possible. For the first time, chapter 3 
demonstrates the capability of developing our unique reduced-sized submicrometric lipobeads to 
quantify chloride ion levels in aqueous samples and biological fluids.  For the first time, an oil-
in-water microemulsion method was used to prepare the lipobeads. This led to forming smaller 
size lipobeads while minimizing the lipobeads aggregation as compared to other submicrometric 
particle-based sensors. From this work, the first lipobead based anion sensor was developed.  
The chloride sensitive dye lucigenin is hydrophilic. To decrease its hydrophilicity and to have it 
become absorbed inside the phospholipids membrane, an ion pair between lucigenin and alkyl 
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hexadecanesulfonate was formed. This resulted in a greater partition rate of the lucigenin dye 
into the membrane of the lipobeads and decreased the leakage of lucigenin from the sensing 
particles.  The modification of lucigenin did not affect its luminescence properties, but did allow 
more lucigenin to be absorbed into the phospholipids membrane. However, the lucigenin 
containing lipobeads were unresponsive to chloride without a chloride ion transport from the 
solution into the membrane. The chloride ionophore [9] mercuracarborand-3 (MC-3) was 
incorporated into the phospholipids membrane for the required chloride transportation.  The 
sensor was highly selective to chloride due to the chloride sensitive indicator lucigenin and 
chloride selective ionophore MC-3.  The response time of the sensor was fast at about 5 seconds. 
With these analytical properties this unique lipobeads sensor demonstrated an effective technique 
for chloride measurement in biological fluids.  
Although the chloride lipobeads sensor was fast and selective to chloride sensing, the 
reproducibility of that sensor was still not good due to the physical absorption of the fluorescent 
indicator into phospholipids membrane of the lipobeads. There always is an improvement by 
covalently attaching phospholipids and fluorescent indicators to the microspheres, however, 
polystyrene microspheres are not an ideal polymer to use for covalent binding in organic solvent 
due to its poor dispersity. Silica particles have been recently used as drug carriers without 
noticeable side effects. Chapter 4 presents a lipobeads fabrication by covalently attaching 
phospholipids and a fluorescent indicator to the silica particles for urea measurement. For the 
first time, this chapter describes the use of submicrometric silica particles as the core of urea 
sensing lipobeads. Silica particles modified with carboxyl groups were coated with 
functionalized phospholipids to form the membrane-coated beads. The lipobeads membrane was 
covalently bound by the enzyme urease and the pH sensitive indicator fluorecein-5-
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thiosemicarbazide. SEM and digital fluorescent images showed that the synthesized lipobeads 
were bright and evenly dispersed, and no apparent aggregation was observed. Immobilization of 
the fluorescent indicator to the lipobeads demonstrated that the response of the immobilized pH 
indicator did not change appreciably due to immobilization. The working range of the 
immobilized fluorescein-5-thiosemicarbazide indicator was between pH 6 and 8.5. Reversibility 
studies indicated that the lipobeads were highly reproducible. The dynamic range was 
determined to be from 0.1 mM to 4 mM. The Michaelis-Menten constant Km for the lipobeads 
particles was 7.0 ± 1.8 mM, 3.7 fold higher than the Km of free urease. This indicated that 
immobilization of urease to the lipobeads membrane decreased the rate of the hydrolase’s 
conversion of urea into ammonia. This was expected due to a diffusion barrier in the lipobeads 
membrane. The comparison between this lipobeads sensor with previously reported particle-
based sensors proves that the lipobead-based biosensor is useful in in-vivo experiments that 
particle endocytosis would be prevented for long term monitoring of urea in serum. The 
phospholipids coating of the particles was previously shown to be effective in lowering the 
endocytotic rate.  
 We observed a very similar dynamic range between the urea lipobeads sensor and a 
previously developed fiber optic sensor that was applied in νiνo. The lipobeads sensor showed a 
potential to be used in vivo. Chapter 5 described the application of avidin-biotin modified 
nanoparticles into cells by using Tat peptide for pH measurement. The strongest noncovalent 
binding between avidin and biotin was used to modify the nanoparticles by attaching Tat peptide 
and flubida-biotin to the surface of the nanoparticles without modifying the peptide properties. 
Flubida is nonfluorescent before penetrating into cells, where it has no background fluorescence 
for pH measurement. There are several methods for nanomaterials penetrating into cells, the 
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most popular and challenging one is to use the Tat peptide. Some progress was made towards the 
application of Tat peptide to the new sensor. The results demonstrated that in PBS buffer, flubida 
did not fluoresce, however, in cell medium, either cell growth medium or serum free medium; 
flubida can be converted to fluorescein before penetrating into the cell membrane, and 
subsequently emitting fluorescence.  
Future work can be done by checking the behavior of the nanoparticles incubated with Hela 
cells in Dulbecco’s PBS buffer for less than 6 hours. Also by replacing the Tat peptide with a 
newly synthesized Tat peptide and by adding a spacer between the nanoparticles and the Tat 
peptide that will allow the Tat peptide to break the cell membrane and let the intruder penetrate 
into the cells. 
Combining this research work with previous studies of lipobeads sensor, it has been 
demonstrated that lipobeads based sensors are noninvasive, biocompatible due to the 
phospholipids membrane, highly reproducible due to the covalent attachment, selective because 
of the sensitive fluorescent indicator and selective ionophore, fast response times which can go 
to subsecond, photostable, and remains stable for a couple of month. My research work 
expanded this lipobeads study, reduced the lipobeads size, minimized the lipobeads aggregation, 
enhanced the lipobeads stability, improved the reproducibility of lipobeads and introduced the 
silica microspheres to the lipobeads system. 
There are some limitations and advantages for this research study. First of all is the 
instrument stability. There is always a ~5% fluctuation for the mercury lamp in the microscopy, 
which will limit the quantitative analysis with digital fluorescence microscopy.  The slits of the 
PTI spectrofluorimeter always vary for every measurement because the slits have to be manually 
operated every time, which limits the repeatability. For the time being, the quantitative analysis 
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can be done by using the multifunction microplate reader, which will minimize the subject error. 
The new spectrofluorimeter being used (Perkin Elmer) can set up the slit by software and 
minimizes the instruments limitation. 
Second is the variability of the cells’ growth stages. The cells were incubated in slightly 
different environments for every batch. So every batch of the cells is slightly different and at 
each batch, the individual cells are at a different growth stage from young to dead cells. This 
greatly affects the nanoparticles penetrating into the cells and the penetrating efficiency varies 
from batch to batch. To minimize the cells variability, a check on the viability of cells for every 
batch used can help to minimize this error. 
  In the future, it is very important to apply the lipobeads based sensor or particle based 
sensor into cells. The particle based sensors have been developed for a couple of decades now, 
and the applications from this development are still limited. It is still a big challenge to deliver 
submicrometric particle based sensors to cells non-invasively.  The development of DNA 
modified particles is a promising direction. The DNA outlayer can be interacted with the cell 
membrane and the cells can engulf the intruder. 
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